{
    "@type": "small molecule",
    "@created": "2016-10-20",
    "@updated": "2023-01-03",
    "drugbank-id": {
        "@primary": "true",
        "#text": "DB12015"
    },
    "name": "Alpelisib",
    "description": "Alpelisib is a phosphatidylinositol 3-kinase (PI3K) inhibitor with potent antitumor activity. It works by selectively inhibiting class I PI3K p110\u03b1 [A179203], which is the catalytic subunit of PI3K, a lipid kinase that plays a role in various biological processes, including proliferation, survival, differentiation, and metabolism. Alpelisib was designed to target this enzyme that appears to be mutated at a rate of nearly 30% in human cancers, leading to hyperactivation.[A179209] \r\n\r\nThere are several isoform-specific PI3K inhibitors that are under clinical development or currently approved, such as [idelalisib] used for chronic lymphocytic leukemia (CLL).[A179209] Approved by the FDA in May 2019, alpelisib is the first approved PI3K inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer in combination with [fulvestrant] for postmenopausal women and male patients. To initiate alpelisib therapy, it is required that the presence of a PIK3CA mutation in the tissue and/or liquid biopsy sample collection should be confirmed via FDA-approved diagnostic tests. Alpelisib is marketed under the trade name Piqray and is available as oral tablets. Studies evaluating the therapeutic effectiveness of alpelisib in other cancers, such as ovarian cancer [A179200] and colorectal cancer [A179203], are under ongoing investigations.\r\n\r\nAlpelisib was granted FDA approval on 24 May 2019.[L6652] In April 2022, the FDA granted the use of alpelisib in the treatment of PIK3CA-Related Overgrowth Spectrum (PROS) in adults and children who require systemic therapy.[L41384]",
    "cas-number": "1217486-61-7",
    "unii": "08W5N2C97Q",
    "average-mass": "441.47",
    "monoisotopic-mass": "441.144630278",
    "state": "solid",
    "groups": {
        "group": [
            "approved",
            "investigational"
        ]
    },
    "general-references": {
        "articles": {
            "article": [
                {
                    "ref-id": "A179200",
                    "pubmed-id": "30880072",
                    "citation": "Konstantinopoulos PA, Barry WT, Birrer M, Westin SN, Cadoo KA, Shapiro GI, Mayer EL, O'Cearbhaill RE, Coleman RL, Kochupurakkal B, Whalen C, Curtis J, Farooq S, Luo W, Eismann J, Buss MK, Aghajanian C, Mills GB, Palakurthi S, Kirschmeier P, Liu J, Cantley LC, Kaufmann SH, Swisher EM, D'Andrea AD, Winer E, Wulf GM, Matulonis UA: Olaparib and alpha-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. Lancet Oncol. 2019 Apr;20(4):570-580. doi: 10.1016/S1470-2045(18)30905-7. Epub 2019 Mar 14."
                },
                {
                    "ref-id": "A179203",
                    "pubmed-id": "30167089",
                    "citation": "Rodon J, Curigliano G, Delord JP, Harb W, Azaro A, Han Y, Wilke C, Donnet V, Sellami D, Beck T: A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors. Oncotarget. 2018 Aug 3;9(60):31709-31718. doi: 10.18632/oncotarget.25854. eCollection 2018 Aug 3."
                },
                {
                    "ref-id": "A179209",
                    "pubmed-id": "29109464",
                    "citation": "Yang X, Zhang X, Huang M, Song K, Li X, Huang M, Meng L, Zhang J: New Insights into PI3K Inhibitor Design using X-ray Structures of PI3Kalpha Complexed with a Potent Lead Compound. Sci Rep. 2017 Nov 6;7(1):14572. doi: 10.1038/s41598-017-15260-5."
                },
                {
                    "ref-id": "A179254",
                    "pubmed-id": "26254025",
                    "citation": "James A, Blumenstein L, Glaenzel U, Jin Y, Demailly A, Jakab A, Hansen R, Hazell K, Mehta A, Trandafir L, Swart P: Absorption, distribution, metabolism, and excretion of [(14)C]BYL719 (alpelisib) in healthy male volunteers. Cancer Chemother Pharmacol. 2015 Oct;76(4):751-60. doi: 10.1007/s00280-015-2842-4. Epub 2015 Aug 8."
                },
                {
                    "ref-id": "A179257",
                    "pubmed-id": "28566285",
                    "citation": "James AD, Marvalin C, Luneau A, Meissner A, Camenisch G: Comparison of (19)F NMR and (14)C Measurements for the Assessment of ADME of BYL719 (Alpelisib) in Humans. Drug Metab Dispos. 2017 Aug;45(8):900-907. doi: 10.1124/dmd.117.075424. Epub 2017 May 31."
                },
                {
                    "ref-id": "A179260",
                    "pubmed-id": "24617631",
                    "citation": "De Buck SS, Jakab A, Boehm M, Bootle D, Juric D, Quadt C, Goggin TK: Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies. Br J Clin Pharmacol. 2014 Sep;78(3):543-55. doi: 10.1111/bcp.12378."
                }
            ]
        },
        "textbooks": null,
        "links": {
            "link": [
                {
                    "ref-id": "L6652",
                    "title": "FDA Approved Drug Products: PIQRAY (alpelisib) tablets, for oral use",
                    "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212526s000lbl.pdf"
                },
                {
                    "ref-id": "L41384",
                    "title": "FDA Approved Drug Products: VIJOICE (alpelisib) tablets, for oral use",
                    "url": "https://www.novartis.us/sites/www.novartis.us/files/vijoice.pdf"
                },
                {
                    "ref-id": "L41389",
                    "title": "Cayman Chemical: Alpelisib MSDS",
                    "url": "https://cdn.caymanchem.com/cdn/msds/16986m.pdf"
                },
                {
                    "ref-id": "L41775",
                    "title": "FDA Approved Drug Products: PIQRAY (alpelisib) tablets, for oral use",
                    "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212526s006lbl.pdf"
                }
            ]
        },
        "attachments": null
    },
    "synthesis-reference": null,
    "indication": "Alpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, and PIK3CA\u00ad mutated. The cancer must be detected by an FDA-approved test following progression on or after an endocrine-based regimen.[L6652]\r\n\r\nAlpelisib is also used to treat adult and pediatric patients two years of age and older with severe manifestations of PIK3CA-Related Overgrowth Spectrum (PROS) who require systemic therapy. This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).[L41384]",
    "pharmacodynamics": "Alpelisib does not prolong the QTcF interval.[L6652] Patients taking alpelisib experience a dose dependent benefit from treatment with a 51% advantage of a 200mg daily dose over a 100mg dose and a 22% advantage of 300mg once daily over 150mg twice daily.[A179260] This suggests patients requiring a lower dose may benefit from twice daily dosing.[A179260]",
    "mechanism-of-action": "Phosphatidylinositol-3-kinase-\u03b1 (PI3K\u03b1) is responsible for cell proliferation in response to growth factor-tyrosine kinase pathway activation.[A179209] In some cancers PI3K\u03b1's p110\u03b1 catalytic subunit is mutated making it hyperactive.[A179209] Alpelisib inhibits (PI3K), with the highest specificity for PI3K\u03b1.[L6652]",
    "toxicity": "Patients experiencing an overdose may present with hyperglycemia, nausea, asthenia, and rash. There is no antidote for an overdose of alpelisib so patients should be treated symptomatically.[L6652] \r\n\r\nData regarding an LD<sub>50</sub> is not readily available.[L41389] In clinical trials, patients were given doses of up to 450mg once daily.[L6652]",
    "metabolism": "Alpelisib is metabolized by hydrolysis reactions to form the primary metabolite. It is also metabolized by CYP3A4.[L6652] The full metabolism of Alpelisib has yet to be determined but a series of reactions have been proposed.[A179254,A179257] The main metabolic reaction is the substitution of an amine group on alpelisib for a hydroxyl group to form a metabolite known as M4[A179254,A179257] or BZG791.[L6652] Alpelisib can also be glucuronidated to form the M1 and M12 metabolites.[A179254,A179257]",
    "absorption": "Alpelisib reached a peak concentration in plasma of 1320\u00b1912ng/mL after 2 hours.[A179254] Alpelisib has an AUC<sub>last</sub> of 11,100\u00b13760h ng/mL and an AUC<sub>INF</sub> of 11,100\u00b13770h ng/mL.[A179254] A large, high fat meal increases the AUC by 73% and C<sub>max</sub> by 84% while a small, low fat meal increases the AUC by 77% and C<sub>max</sub> by 145%.[L6652]",
    "half-life": "The mean half life of alprelisib is 8 to 9 hours.[L6652]",
    "protein-binding": "Alpelisib is 89% protein bound.[L6652]",
    "route-of-elimination": "36% of an oral dose is eliminated as unchanged drug in the feces and 32% as the primary metabolite BZG791 in the feces. About 2% of an oral dose is eliminated in the urine as unchanged drug and 7.1% as the primary metabolite BZG791. In total 81% of an oral dose is eliminated in the feces and 14% is eliminated in the urine.[L6652]",
    "volume-of-distribution": "The apparent volume of distribution at steady state is 114L.[L6652]",
    "clearance": "The mean apparent oral clearance was 39.0L/h.[A179254] The predicted clearance is 9.2L/hr under fed conditions.[L6652]",
    "classification": {
        "description": "This compound belongs to the class of organic compounds known as proline and derivatives. These are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.",
        "direct-parent": "Proline and derivatives",
        "kingdom": "Organic compounds",
        "superclass": "Organic acids and derivatives",
        "class": "Carboxylic acids and derivatives",
        "subclass": "Amino acids, peptides, and analogues",
        "alternative-parent": [
            "2,4,5-trisubstituted thiazoles",
            "Alkyl fluorides",
            "Alpha amino acid amides",
            "Azacyclic compounds",
            "Carbonyl compounds",
            "Heteroaromatic compounds",
            "Hydrocarbon derivatives",
            "Organic oxides",
            "Organofluorides",
            "Organonitrogen compounds",
            "Organopnictogen compounds",
            "Primary carboxylic acid amides",
            "Pyridines and derivatives",
            "Pyrrolidinecarboxamides",
            "Ureas"
        ],
        "substituent": [
            "2,4,5-trisubstituted 1,3-thiazole",
            "Alkyl fluoride",
            "Alkyl halide",
            "Alpha-amino acid amide",
            "Aromatic heteromonocyclic compound",
            "Azacycle",
            "Azole",
            "Carbonic acid derivative",
            "Carbonyl group",
            "Carboxamide group",
            "Heteroaromatic compound",
            "Hydrocarbon derivative",
            "Organic nitrogen compound",
            "Organic oxide",
            "Organic oxygen compound",
            "Organofluoride",
            "Organohalogen compound",
            "Organoheterocyclic compound",
            "Organonitrogen compound",
            "Organooxygen compound",
            "Organopnictogen compound",
            "Primary carboxylic acid amide",
            "Proline or derivatives",
            "Pyridine",
            "Pyrrolidine",
            "Pyrrolidine carboxylic acid or derivatives",
            "Pyrrolidine-1-carboxamide",
            "Pyrrolidine-2-carboxamide",
            "Thiazole",
            "Urea"
        ]
    },
    "salts": null,
    "synonyms": {
        "synonym": {
            "@language": "english",
            "@coder": "inn/usan",
            "#text": "Alpelisib"
        }
    },
    "products": {
        "product": [
            {
                "name": "Piqray",
                "labeller": "Novartis",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": "02497042",
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": null,
                "ended-marketing-on": null,
                "dosage-form": "Tablet",
                "strength": "50 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "Canada",
                "source": "DPD"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": "02497069",
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2020-06-29",
                "ended-marketing-on": null,
                "dosage-form": "Tablet",
                "strength": "150 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "Canada",
                "source": "DPD"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": "02497077",
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2020-06-29",
                "ended-marketing-on": null,
                "dosage-form": "Tablet",
                "strength": "200 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "Canada",
                "source": "DPD"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": "02497085",
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2020-06-29",
                "ended-marketing-on": null,
                "dosage-form": "Kit; Tablet",
                "strength": null,
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "Canada",
                "source": "DPD"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": "02497085",
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2020-06-29",
                "ended-marketing-on": null,
                "dosage-form": "Kit; Tablet",
                "strength": null,
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "Canada",
                "source": "DPD"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Europharm Limited",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": null,
                "ema-product-code": "EMEA/H/C/004804",
                "ema-ma-number": "EU/1/20/1455/001",
                "started-marketing-on": "2020-12-16",
                "ended-marketing-on": null,
                "dosage-form": "Tablet, film coated",
                "strength": "150 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "EU",
                "source": "EMA"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Europharm Limited",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": null,
                "ema-product-code": "EMEA/H/C/004804",
                "ema-ma-number": "EU/1/20/1455/002",
                "started-marketing-on": "2020-12-16",
                "ended-marketing-on": null,
                "dosage-form": "Tablet, film coated",
                "strength": "150 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "EU",
                "source": "EMA"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Europharm Limited",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": null,
                "ema-product-code": "EMEA/H/C/004804",
                "ema-ma-number": "EU/1/20/1455/003",
                "started-marketing-on": "2020-12-16",
                "ended-marketing-on": null,
                "dosage-form": "Tablet, film coated",
                "strength": "150 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "EU",
                "source": "EMA"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Europharm Limited",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": null,
                "ema-product-code": "EMEA/H/C/004804",
                "ema-ma-number": "EU/1/20/1455/007",
                "started-marketing-on": "2020-12-16",
                "ended-marketing-on": null,
                "dosage-form": "Tablet, film coated",
                "strength": "200 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "EU",
                "source": "EMA"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Europharm Limited",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": null,
                "ema-product-code": "EMEA/H/C/004804",
                "ema-ma-number": "EU/1/20/1455/008",
                "started-marketing-on": "2020-12-16",
                "ended-marketing-on": null,
                "dosage-form": "Tablet, film coated",
                "strength": "200 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "EU",
                "source": "EMA"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Europharm Limited",
                "ndc-id": null,
                "ndc-product-code": null,
                "dpd-id": null,
                "ema-product-code": "EMEA/H/C/004804",
                "ema-ma-number": "EU/1/20/1455/009",
                "started-marketing-on": "2020-12-16",
                "ended-marketing-on": null,
                "dosage-form": "Tablet, film coated",
                "strength": "200 mg",
                "route": "Oral",
                "fda-application-number": null,
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "EU",
                "source": "EMA"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Pharmaceuticals Corporation",
                "ndc-id": null,
                "ndc-product-code": "0078-0708",
                "dpd-id": null,
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2019-05-24",
                "ended-marketing-on": null,
                "dosage-form": "Tablet",
                "strength": "150 mg/1",
                "route": "Oral",
                "fda-application-number": "NDA212526",
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "US",
                "source": "FDA NDC"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Pharmaceuticals Corporation",
                "ndc-id": null,
                "ndc-product-code": "0078-0715",
                "dpd-id": null,
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2019-05-24",
                "ended-marketing-on": null,
                "dosage-form": "Kit; Tablet",
                "strength": null,
                "route": "Oral",
                "fda-application-number": "NDA212526",
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "US",
                "source": "FDA NDC"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Pharmaceuticals Corporation",
                "ndc-id": null,
                "ndc-product-code": "0078-0715",
                "dpd-id": null,
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2019-05-24",
                "ended-marketing-on": null,
                "dosage-form": "Kit; Tablet",
                "strength": null,
                "route": "Oral",
                "fda-application-number": "NDA212526",
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "US",
                "source": "FDA NDC"
            },
            {
                "name": "Piqray",
                "labeller": "Novartis Pharmaceuticals Corporation",
                "ndc-id": null,
                "ndc-product-code": "0078-0701",
                "dpd-id": null,
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2019-05-24",
                "ended-marketing-on": null,
                "dosage-form": "Tablet",
                "strength": "200 mg/1",
                "route": "Oral",
                "fda-application-number": "NDA212526",
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "US",
                "source": "FDA NDC"
            },
            {
                "name": "Vijoice",
                "labeller": "Novartis Pharmaceuticals Corporation",
                "ndc-id": null,
                "ndc-product-code": "0078-1021",
                "dpd-id": null,
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2022-04-05",
                "ended-marketing-on": null,
                "dosage-form": "Tablet",
                "strength": "50 mg/1",
                "route": "Oral",
                "fda-application-number": "NDA215039",
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "US",
                "source": "FDA NDC"
            },
            {
                "name": "Vijoice",
                "labeller": "Novartis Pharmaceuticals Corporation",
                "ndc-id": null,
                "ndc-product-code": "0078-1028",
                "dpd-id": null,
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2022-04-05",
                "ended-marketing-on": null,
                "dosage-form": "Tablet",
                "strength": "125 mg/1",
                "route": "Oral",
                "fda-application-number": "NDA215039",
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "US",
                "source": "FDA NDC"
            },
            {
                "name": "Vijoice",
                "labeller": "Novartis Pharmaceuticals Corporation",
                "ndc-id": null,
                "ndc-product-code": "0078-1035",
                "dpd-id": null,
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2022-04-05",
                "ended-marketing-on": null,
                "dosage-form": "Kit; Tablet",
                "strength": null,
                "route": "Oral",
                "fda-application-number": "NDA215039",
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "US",
                "source": "FDA NDC"
            },
            {
                "name": "Vijoice",
                "labeller": "Novartis Pharmaceuticals Corporation",
                "ndc-id": null,
                "ndc-product-code": "0078-1035",
                "dpd-id": null,
                "ema-product-code": null,
                "ema-ma-number": null,
                "started-marketing-on": "2022-04-05",
                "ended-marketing-on": null,
                "dosage-form": "Kit; Tablet",
                "strength": null,
                "route": "Oral",
                "fda-application-number": "NDA215039",
                "generic": "false",
                "over-the-counter": "false",
                "approved": "true",
                "country": "US",
                "source": "FDA NDC"
            }
        ]
    },
    "international-brands": null,
    "mixtures": {
        "mixture": [
            {
                "name": "Piqray",
                "ingredients": "Alpelisib + Alpelisib"
            },
            {
                "name": "Piqray",
                "ingredients": "Alpelisib + Alpelisib"
            },
            {
                "name": "Piqray",
                "ingredients": "Alpelisib + Alpelisib"
            },
            {
                "name": "Piqray",
                "ingredients": "Alpelisib + Alpelisib"
            },
            {
                "name": "Vijoice",
                "ingredients": "Alpelisib + Alpelisib"
            },
            {
                "name": "Vijoice",
                "ingredients": "Alpelisib + Alpelisib"
            }
        ]
    },
    "packagers": null,
    "manufacturers": null,
    "prices": null,
    "categories": {
        "category": [
            {
                "category": "Antineoplastic Agents",
                "mesh-id": "D000970"
            },
            {
                "category": "Antineoplastic and Immunomodulating Agents",
                "mesh-id": null
            },
            {
                "category": "BCRP/ABCG2 Inhibitors",
                "mesh-id": null
            },
            {
                "category": "BCRP/ABCG2 Substrates",
                "mesh-id": null
            },
            {
                "category": "Breast Neoplasms",
                "mesh-id": "D001943"
            },
            {
                "category": "Cytochrome P-450 CYP2B6 Inducers",
                "mesh-id": "D065695"
            },
            {
                "category": "Cytochrome P-450 CYP2B6 Inducers (moderate)",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP2C19 Inhibitors",
                "mesh-id": "D065689"
            },
            {
                "category": "Cytochrome P-450 CYP2C19 inhibitors (strength unknown)",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP2C8 Inhibitors",
                "mesh-id": "D065687"
            },
            {
                "category": "Cytochrome P-450 CYP2C8 Inhibitors (strength unknown)",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP2C9 Inducers",
                "mesh-id": "D065698"
            },
            {
                "category": "Cytochrome P-450 CYP2C9 Inducers (moderate)",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP2C9 Inducers (strength unknown)",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP3A Inducers",
                "mesh-id": "D065701"
            },
            {
                "category": "Cytochrome P-450 CYP3A Inhibitors",
                "mesh-id": "D065692"
            },
            {
                "category": "Cytochrome P-450 CYP3A Substrates",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP3A4 Inducers",
                "mesh-id": "D065701"
            },
            {
                "category": "Cytochrome P-450 CYP3A4 Inducers (weak)",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP3A4 Inhibitors",
                "mesh-id": "D065692"
            },
            {
                "category": "Cytochrome P-450 CYP3A4 Inhibitors (weak)",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP3A4 Substrates",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP3A4 Substrates (strength unknown)",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic Index",
                "mesh-id": null
            },
            {
                "category": "Cytochrome P-450 Enzyme Inducers",
                "mesh-id": "D065693"
            },
            {
                "category": "Cytochrome P-450 Enzyme Inhibitors",
                "mesh-id": "D065607"
            },
            {
                "category": "Cytochrome P-450 Substrates",
                "mesh-id": null
            },
            {
                "category": "Kinase Inhibitor",
                "mesh-id": null
            },
            {
                "category": "Narrow Therapeutic Index Drugs",
                "mesh-id": null
            },
            {
                "category": "P-glycoprotein inhibitors",
                "mesh-id": null
            },
            {
                "category": "Phosphatidylinositol 3-Kinases, antagonists & inhibitors",
                "mesh-id": null
            },
            {
                "category": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
                "mesh-id": null
            },
            {
                "category": "Protein Kinase Inhibitors",
                "mesh-id": "D047428"
            },
            {
                "category": "Sulfur Compounds",
                "mesh-id": "D013457"
            }
        ]
    },
    "affected-organisms": null,
    "dosages": {
        "dosage": [
            {
                "form": "Kit; tablet",
                "route": "Oral",
                "strength": null
            },
            {
                "form": "Kit; tablet, film coated",
                "route": "Oral",
                "strength": null
            },
            {
                "form": "Tablet",
                "route": "Oral",
                "strength": "150 mg"
            },
            {
                "form": "Tablet",
                "route": "Oral",
                "strength": "150 mg/1"
            },
            {
                "form": "Tablet",
                "route": "Oral",
                "strength": "200 mg/1"
            },
            {
                "form": "Tablet",
                "route": "Oral",
                "strength": "200 mg"
            },
            {
                "form": "Tablet",
                "route": "Oral",
                "strength": "50 mg"
            },
            {
                "form": "Tablet, film coated",
                "route": "Oral",
                "strength": "150 MG"
            },
            {
                "form": "Tablet, film coated",
                "route": "Oral",
                "strength": "200 MG"
            },
            {
                "form": "Tablet, film coated",
                "route": "Oral",
                "strength": null
            },
            {
                "form": "Tablet",
                "route": "Oral",
                "strength": "125 mg/1"
            },
            {
                "form": "Tablet",
                "route": "Oral",
                "strength": "50 mg/1"
            }
        ]
    },
    "atc-codes": {
        "atc-code": {
            "@code": "L01EM03",
            "level": [
                {
                    "@code": "L01EM",
                    "#text": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors"
                },
                {
                    "@code": "L01E",
                    "#text": "PROTEIN KINASE INHIBITORS"
                },
                {
                    "@code": "L01",
                    "#text": "ANTINEOPLASTIC AGENTS"
                },
                {
                    "@code": "L",
                    "#text": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS"
                }
            ]
        }
    },
    "ahfs-codes": null,
    "pdb-entries": {
        "pdb-entry": [
            "4jps",
            "7myo",
            "7pg6",
            "8gua",
            "8gub",
            "8gud"
        ]
    },
    "patents": {
        "patent": [
            {
                "number": "8227462",
                "country": "United States",
                "approved": "2012-07-24",
                "expires": "2030-09-28",
                "pediatric-extension": "false"
            },
            {
                "number": "8476268",
                "country": "United States",
                "approved": "2013-07-02",
                "expires": "2029-09-10",
                "pediatric-extension": "false"
            }
        ]
    },
    "food-interactions": {
        "food-interaction": [
            "Exercise caution with St. John's Wort. This herb induces CYP3A metabolism and may reduce serum levels of alpelisib.",
            "Take at the same time every day.",
            "Take with food. Food does not significantly affect the AUC of alpelisib."
        ]
    },
    "drug-interactions": {
        "drug-interaction": [
            {
                "drugbank-id": "DB00745",
                "name": "Modafinil",
                "description": "The metabolism of Alpelisib can be increased when combined with Modafinil."
            },
            {
                "drugbank-id": "DB06413",
                "name": "Armodafinil",
                "description": "The metabolism of Alpelisib can be increased when combined with Armodafinil."
            },
            {
                "drugbank-id": "DB08827",
                "name": "Lomitapide",
                "description": "The metabolism of Lomitapide can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01238",
                "name": "Aripiprazole",
                "description": "The metabolism of Aripiprazole can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB14185",
                "name": "Aripiprazole lauroxil",
                "description": "The metabolism of Aripiprazole lauroxil can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09039",
                "name": "Eliglustat",
                "description": "The metabolism of Eliglustat can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09053",
                "name": "Ibrutinib",
                "description": "The metabolism of Ibrutinib can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01166",
                "name": "Cilostazol",
                "description": "The metabolism of Cilostazol can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01394",
                "name": "Colchicine",
                "description": "The metabolism of Colchicine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00813",
                "name": "Fentanyl",
                "description": "The metabolism of Fentanyl can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04946",
                "name": "Iloperidone",
                "description": "The metabolism of Iloperidone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01256",
                "name": "Retapamulin",
                "description": "The metabolism of Retapamulin can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08895",
                "name": "Tofacitinib",
                "description": "The metabolism of Tofacitinib can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00862",
                "name": "Vardenafil",
                "description": "The metabolism of Vardenafil can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00227",
                "name": "Lovastatin",
                "description": "The metabolism of Lovastatin can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09046",
                "name": "Metreleptin",
                "description": "The metabolism of Alpelisib can be increased when combined with Metreleptin."
            },
            {
                "drugbank-id": "DB00346",
                "name": "Alfuzosin",
                "description": "The metabolism of Alfuzosin can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00404",
                "name": "Alprazolam",
                "description": "The metabolism of Alprazolam can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01181",
                "name": "Ifosfamide",
                "description": "The metabolism of Ifosfamide can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08883",
                "name": "Perampanel",
                "description": "The metabolism of Perampanel can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08735",
                "name": "R,S-Warfarin alcohol",
                "description": "The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08736",
                "name": "S,R-Warfarin alcohol",
                "description": "The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00683",
                "name": "Midazolam",
                "description": "The serum concentration of Midazolam can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00864",
                "name": "Tacrolimus",
                "description": "The serum concentration of Tacrolimus can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08865",
                "name": "Crizotinib",
                "description": "The metabolism of Alpelisib can be decreased when combined with Crizotinib."
            },
            {
                "drugbank-id": "DB01076",
                "name": "Atorvastatin",
                "description": "The metabolism of Atorvastatin can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00530",
                "name": "Erlotinib",
                "description": "The serum concentration of Erlotinib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11642",
                "name": "Pitolisant",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Pitolisant."
            },
            {
                "drugbank-id": "DB14583",
                "name": "Segesterone acetate",
                "description": "The metabolism of Segesterone acetate can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04540",
                "name": "Cholesterol",
                "description": "Cholesterol may increase the excretion rate of Alpelisib which could result in a lower serum level and potentially a reduction in efficacy."
            },
            {
                "drugbank-id": "DB00294",
                "name": "Etonogestrel",
                "description": "The metabolism of Etonogestrel can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00367",
                "name": "Levonorgestrel",
                "description": "The metabolism of Levonorgestrel can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00823",
                "name": "Ethynodiol diacetate",
                "description": "The metabolism of Ethynodiol diacetate can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04066",
                "name": "p-Coumaric acid",
                "description": "The metabolism of p-Coumaric acid can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04682",
                "name": "Octylphenoxy polyethoxyethanol",
                "description": "The metabolism of Octylphenoxy polyethoxyethanol can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB05830",
                "name": "Trestolone",
                "description": "The metabolism of Trestolone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06266",
                "name": "Lonidamine",
                "description": "The metabolism of Lonidamine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06713",
                "name": "Norelgestromin",
                "description": "The metabolism of Norelgestromin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06730",
                "name": "Gestodene",
                "description": "The metabolism of Gestodene can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06789",
                "name": "Hydroxyprogesterone caproate",
                "description": "The metabolism of Hydroxyprogesterone caproate can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09123",
                "name": "Dienogest",
                "description": "The metabolism of Dienogest can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09371",
                "name": "Norethynodrel",
                "description": "The metabolism of Norethynodrel can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09389",
                "name": "Norgestrel",
                "description": "The metabolism of Norgestrel can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11507",
                "name": "Cloprostenol",
                "description": "The metabolism of Cloprostenol can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11619",
                "name": "Gestrinone",
                "description": "The metabolism of Gestrinone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11636",
                "name": "Nomegestrol",
                "description": "The metabolism of Nomegestrol can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12025",
                "name": "Triptolide",
                "description": "The metabolism of Triptolide can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13044",
                "name": "Gossypol",
                "description": "The metabolism of Gossypol can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13310",
                "name": "Ormeloxifene",
                "description": "The metabolism of Ormeloxifene can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13528",
                "name": "Chlormadinone",
                "description": "The metabolism of Chlormadinone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13563",
                "name": "Norgestrienone",
                "description": "The metabolism of Norgestrienone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13685",
                "name": "Quingestanol",
                "description": "The metabolism of Quingestanol can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13857",
                "name": "Demegestone",
                "description": "The metabolism of Demegestone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13866",
                "name": "Etynodiol",
                "description": "The metabolism of Etynodiol can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13981",
                "name": "Nomegestrol acetate",
                "description": "The metabolism of Nomegestrol acetate can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB14678",
                "name": "Norethindrone enanthate",
                "description": "The metabolism of Norethindrone enanthate can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08867",
                "name": "Ulipristal",
                "description": "The metabolism of Ulipristal can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00351",
                "name": "Megestrol acetate",
                "description": "The metabolism of Megestrol acetate can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00607",
                "name": "Nafcillin",
                "description": "The metabolism of Alpelisib can be increased when combined with Nafcillin."
            },
            {
                "drugbank-id": "DB06442",
                "name": "Avasimibe",
                "description": "The metabolism of Alpelisib can be increased when combined with Avasimibe."
            },
            {
                "drugbank-id": "DB14240",
                "name": "Echinacea",
                "description": "The metabolism of Alpelisib can be increased when combined with Echinacea."
            },
            {
                "drugbank-id": "DB00204",
                "name": "Dofetilide",
                "description": "The metabolism of Dofetilide can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00277",
                "name": "Theophylline",
                "description": "The metabolism of Theophylline can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01008",
                "name": "Busulfan",
                "description": "The metabolism of Busulfan can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01100",
                "name": "Pimozide",
                "description": "The metabolism of Pimozide can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01223",
                "name": "Aminophylline",
                "description": "The metabolism of Aminophylline can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09289",
                "name": "Tianeptine",
                "description": "The metabolism of Tianeptine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00615",
                "name": "Rifabutin",
                "description": "The metabolism of Alpelisib can be increased when combined with Rifabutin."
            },
            {
                "drugbank-id": "DB00949",
                "name": "Felbamate",
                "description": "The metabolism of Alpelisib can be increased when combined with Felbamate."
            },
            {
                "drugbank-id": "DB04911",
                "name": "Oritavancin",
                "description": "The metabolism of Alpelisib can be increased when combined with Oritavancin."
            },
            {
                "drugbank-id": "DB06201",
                "name": "Rufinamide",
                "description": "The metabolism of Alpelisib can be increased when combined with Rufinamide."
            },
            {
                "drugbank-id": "DB08909",
                "name": "Glycerol phenylbutyrate",
                "description": "The metabolism of Alpelisib can be increased when combined with Glycerol phenylbutyrate."
            },
            {
                "drugbank-id": "DB09119",
                "name": "Eslicarbazepine acetate",
                "description": "The metabolism of Alpelisib can be increased when combined with Eslicarbazepine acetate."
            },
            {
                "drugbank-id": "DB11767",
                "name": "Sarilumab",
                "description": "The metabolism of Alpelisib can be increased when combined with Sarilumab."
            },
            {
                "drugbank-id": "DB11703",
                "name": "Acalabrutinib",
                "description": "The metabolism of Acalabrutinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00273",
                "name": "Topiramate",
                "description": "The metabolism of Alpelisib can be increased when combined with Topiramate."
            },
            {
                "drugbank-id": "DB05239",
                "name": "Cobimetinib",
                "description": "The metabolism of Cobimetinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00877",
                "name": "Sirolimus",
                "description": "The metabolism of Sirolimus can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01396",
                "name": "Digitoxin",
                "description": "The metabolism of Digitoxin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01590",
                "name": "Everolimus",
                "description": "The metabolism of Everolimus can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06287",
                "name": "Temsirolimus",
                "description": "The metabolism of Temsirolimus can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00570",
                "name": "Vinblastine",
                "description": "The metabolism of Vinblastine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00997",
                "name": "Doxorubicin",
                "description": "The metabolism of Doxorubicin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01248",
                "name": "Docetaxel",
                "description": "The metabolism of Docetaxel can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00762",
                "name": "Irinotecan",
                "description": "The metabolism of Irinotecan can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06176",
                "name": "Romidepsin",
                "description": "The metabolism of Romidepsin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06626",
                "name": "Axitinib",
                "description": "The metabolism of Axitinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01242",
                "name": "Clomipramine",
                "description": "The metabolism of Clomipramine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00563",
                "name": "Methotrexate",
                "description": "The metabolism of Methotrexate can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00361",
                "name": "Vinorelbine",
                "description": "The metabolism of Vinorelbine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00541",
                "name": "Vincristine",
                "description": "The metabolism of Vincristine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04572",
                "name": "Thiotepa",
                "description": "The metabolism of Thiotepa can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11641",
                "name": "Vinflunine",
                "description": "The metabolism of Vinflunine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB15035",
                "name": "Zanubrutinib",
                "description": "The metabolism of Zanubrutinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00309",
                "name": "Vindesine",
                "description": "The metabolism of Vindesine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06603",
                "name": "Panobinostat",
                "description": "The metabolism of Panobinostat can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09143",
                "name": "Sonidegib",
                "description": "The metabolism of Sonidegib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11828",
                "name": "Neratinib",
                "description": "The metabolism of Neratinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12483",
                "name": "Copanlisib",
                "description": "The metabolism of Copanlisib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12978",
                "name": "Pexidartinib",
                "description": "The metabolism of Pexidartinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09054",
                "name": "Idelalisib",
                "description": "The metabolism of Idelalisib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04845",
                "name": "Ixabepilone",
                "description": "The metabolism of Ixabepilone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09570",
                "name": "Ixazomib",
                "description": "The metabolism of Ixazomib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00575",
                "name": "Clonidine",
                "description": "The metabolism of Clonidine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06212",
                "name": "Tolvaptan",
                "description": "The metabolism of Tolvaptan can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08910",
                "name": "Pomalidomide",
                "description": "The metabolism of Pomalidomide can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00540",
                "name": "Nortriptyline",
                "description": "The metabolism of Nortriptyline can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01227",
                "name": "Levacetylmethadol",
                "description": "The metabolism of Levacetylmethadol can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00908",
                "name": "Quinidine",
                "description": "The metabolism of Quinidine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00603",
                "name": "Medroxyprogesterone acetate",
                "description": "The metabolism of Alpelisib can be increased when combined with Medroxyprogesterone acetate."
            },
            {
                "drugbank-id": "DB00849",
                "name": "Methylphenobarbital",
                "description": "The metabolism of Alpelisib can be increased when combined with Methylphenobarbital."
            },
            {
                "drugbank-id": "DB01483",
                "name": "Barbital",
                "description": "The metabolism of Alpelisib can be increased when combined with Barbital."
            },
            {
                "drugbank-id": "DB14512",
                "name": "Mometasone furoate",
                "description": "The metabolism of Alpelisib can be increased when combined with Mometasone furoate."
            },
            {
                "drugbank-id": "DB01138",
                "name": "Sulfinpyrazone",
                "description": "The metabolism of Alpelisib can be increased when combined with Sulfinpyrazone."
            },
            {
                "drugbank-id": "DB00136",
                "name": "Calcitriol",
                "description": "The metabolism of Alpelisib can be increased when combined with Calcitriol."
            },
            {
                "drugbank-id": "DB00163",
                "name": "Vitamin E",
                "description": "The metabolism of Alpelisib can be increased when combined with Vitamin E."
            },
            {
                "drugbank-id": "DB00180",
                "name": "Flunisolide",
                "description": "The metabolism of Alpelisib can be increased when combined with Flunisolide."
            },
            {
                "drugbank-id": "DB00241",
                "name": "Butalbital",
                "description": "The metabolism of Alpelisib can be increased when combined with Butalbital."
            },
            {
                "drugbank-id": "DB00301",
                "name": "Flucloxacillin",
                "description": "The metabolism of Alpelisib can be increased when combined with Flucloxacillin."
            },
            {
                "drugbank-id": "DB00357",
                "name": "Aminoglutethimide",
                "description": "The metabolism of Alpelisib can be increased when combined with Aminoglutethimide."
            },
            {
                "drugbank-id": "DB00400",
                "name": "Griseofulvin",
                "description": "The metabolism of Alpelisib can be increased when combined with Griseofulvin."
            },
            {
                "drugbank-id": "DB00418",
                "name": "Secobarbital",
                "description": "The metabolism of Alpelisib can be increased when combined with Secobarbital."
            },
            {
                "drugbank-id": "DB00485",
                "name": "Dicloxacillin",
                "description": "The metabolism of Alpelisib can be increased when combined with Dicloxacillin."
            },
            {
                "drugbank-id": "DB00591",
                "name": "Fluocinolone acetonide",
                "description": "The metabolism of Alpelisib can be increased when combined with Fluocinolone acetonide."
            },
            {
                "drugbank-id": "DB00620",
                "name": "Triamcinolone",
                "description": "The metabolism of Alpelisib can be increased when combined with Triamcinolone."
            },
            {
                "drugbank-id": "DB00636",
                "name": "Clofibrate",
                "description": "The metabolism of Alpelisib can be increased when combined with Clofibrate."
            },
            {
                "drugbank-id": "DB00769",
                "name": "Hydrocortamate",
                "description": "The metabolism of Alpelisib can be increased when combined with Hydrocortamate."
            },
            {
                "drugbank-id": "DB00898",
                "name": "Ethanol",
                "description": "The metabolism of Alpelisib can be increased when combined with Ethanol."
            },
            {
                "drugbank-id": "DB01011",
                "name": "Metyrapone",
                "description": "The metabolism of Alpelisib can be increased when combined with Metyrapone."
            },
            {
                "drugbank-id": "DB01032",
                "name": "Probenecid",
                "description": "The metabolism of Alpelisib can be increased when combined with Probenecid."
            },
            {
                "drugbank-id": "DB01201",
                "name": "Rifapentine",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Rifapentine."
            },
            {
                "drugbank-id": "DB01285",
                "name": "Corticotropin",
                "description": "The metabolism of Alpelisib can be increased when combined with Corticotropin."
            },
            {
                "drugbank-id": "DB01333",
                "name": "Cefradine",
                "description": "The metabolism of Alpelisib can be increased when combined with Cefradine."
            },
            {
                "drugbank-id": "DB01351",
                "name": "Amobarbital",
                "description": "The metabolism of Alpelisib can be increased when combined with Amobarbital."
            },
            {
                "drugbank-id": "DB01352",
                "name": "Aprobarbital",
                "description": "The metabolism of Alpelisib can be increased when combined with Aprobarbital."
            },
            {
                "drugbank-id": "DB01380",
                "name": "Cortisone acetate",
                "description": "The metabolism of Alpelisib can be increased when combined with Cortisone acetate."
            },
            {
                "drugbank-id": "DB01384",
                "name": "Paramethasone",
                "description": "The metabolism of Alpelisib can be increased when combined with Paramethasone."
            },
            {
                "drugbank-id": "DB01609",
                "name": "Deferasirox",
                "description": "The metabolism of Alpelisib can be increased when combined with Deferasirox."
            },
            {
                "drugbank-id": "DB04920",
                "name": "Clevidipine",
                "description": "The metabolism of Alpelisib can be increased when combined with Clevidipine."
            },
            {
                "drugbank-id": "DB08905",
                "name": "Formestane",
                "description": "The metabolism of Alpelisib can be increased when combined with Formestane."
            },
            {
                "drugbank-id": "DB08970",
                "name": "Fluprednidene",
                "description": "The metabolism of Alpelisib can be increased when combined with Fluprednidene."
            },
            {
                "drugbank-id": "DB09001",
                "name": "Barbexaclone",
                "description": "The metabolism of Alpelisib can be increased when combined with Barbexaclone."
            },
            {
                "drugbank-id": "DB09383",
                "name": "Meprednisone",
                "description": "The metabolism of Alpelisib can be increased when combined with Meprednisone."
            },
            {
                "drugbank-id": "DB11487",
                "name": "Dexamethasone isonicotinate",
                "description": "The metabolism of Alpelisib can be increased when combined with Dexamethasone isonicotinate."
            },
            {
                "drugbank-id": "DB11921",
                "name": "Deflazacort",
                "description": "The metabolism of Alpelisib can be increased when combined with Deflazacort."
            },
            {
                "drugbank-id": "DB13003",
                "name": "Cortivazol",
                "description": "The metabolism of Alpelisib can be increased when combined with Cortivazol."
            },
            {
                "drugbank-id": "DB13208",
                "name": "Prednylidene",
                "description": "The metabolism of Alpelisib can be increased when combined with Prednylidene."
            },
            {
                "drugbank-id": "DB13843",
                "name": "Cloprednol",
                "description": "The metabolism of Alpelisib can be increased when combined with Cloprednol."
            },
            {
                "drugbank-id": "DB14539",
                "name": "Hydrocortisone acetate",
                "description": "The metabolism of Alpelisib can be increased when combined with Hydrocortisone acetate."
            },
            {
                "drugbank-id": "DB14545",
                "name": "Hydrocortisone succinate",
                "description": "The metabolism of Alpelisib can be increased when combined with Hydrocortisone succinate."
            },
            {
                "drugbank-id": "DB14631",
                "name": "Prednisolone phosphate",
                "description": "The metabolism of Alpelisib can be increased when combined with Prednisolone phosphate."
            },
            {
                "drugbank-id": "DB14633",
                "name": "Prednisolone hemisuccinate",
                "description": "The metabolism of Alpelisib can be increased when combined with Prednisolone hemisuccinate."
            },
            {
                "drugbank-id": "DB14646",
                "name": "Prednisone acetate",
                "description": "The metabolism of Alpelisib can be increased when combined with Prednisone acetate."
            },
            {
                "drugbank-id": "DB14652",
                "name": "Clocortolone acetate",
                "description": "The metabolism of Alpelisib can be increased when combined with Clocortolone acetate."
            },
            {
                "drugbank-id": "DB14659",
                "name": "Melengestrol acetate",
                "description": "The metabolism of Alpelisib can be increased when combined with Melengestrol acetate."
            },
            {
                "drugbank-id": "DB14669",
                "name": "Betamethasone phosphate",
                "description": "The metabolism of Alpelisib can be increased when combined with Betamethasone phosphate."
            },
            {
                "drugbank-id": "DB14681",
                "name": "Cortisone",
                "description": "The metabolism of Alpelisib can be increased when combined with Cortisone."
            },
            {
                "drugbank-id": "DB14575",
                "name": "Eslicarbazepine",
                "description": "The metabolism of Alpelisib can be increased when combined with Eslicarbazepine."
            },
            {
                "drugbank-id": "DB06717",
                "name": "Fosaprepitant",
                "description": "The metabolism of Alpelisib can be increased when combined with Fosaprepitant."
            },
            {
                "drugbank-id": "DB00477",
                "name": "Chlorpromazine",
                "description": "The metabolism of Alpelisib can be increased when combined with Chlorpromazine."
            },
            {
                "drugbank-id": "DB00316",
                "name": "Acetaminophen",
                "description": "The metabolism of Alpelisib can be increased when combined with Acetaminophen."
            },
            {
                "drugbank-id": "DB00349",
                "name": "Clobazam",
                "description": "The metabolism of Alpelisib can be increased when combined with Clobazam."
            },
            {
                "drugbank-id": "DB00439",
                "name": "Cerivastatin",
                "description": "The metabolism of Alpelisib can be increased when combined with Cerivastatin."
            },
            {
                "drugbank-id": "DB00443",
                "name": "Betamethasone",
                "description": "The metabolism of Alpelisib can be increased when combined with Betamethasone."
            },
            {
                "drugbank-id": "DB00776",
                "name": "Oxcarbazepine",
                "description": "The metabolism of Alpelisib can be increased when combined with Oxcarbazepine."
            },
            {
                "drugbank-id": "DB00834",
                "name": "Mifepristone",
                "description": "The metabolism of Alpelisib can be increased when combined with Mifepristone."
            },
            {
                "drugbank-id": "DB00860",
                "name": "Prednisolone",
                "description": "The metabolism of Alpelisib can be increased when combined with Prednisolone."
            },
            {
                "drugbank-id": "DB00959",
                "name": "Methylprednisolone",
                "description": "The metabolism of Alpelisib can be increased when combined with Methylprednisolone."
            },
            {
                "drugbank-id": "DB01222",
                "name": "Budesonide",
                "description": "The metabolism of Alpelisib can be increased when combined with Budesonide."
            },
            {
                "drugbank-id": "DB04905",
                "name": "Tesmilifene",
                "description": "The metabolism of Alpelisib can be increased when combined with Tesmilifene."
            },
            {
                "drugbank-id": "DB08906",
                "name": "Fluticasone furoate",
                "description": "The metabolism of Alpelisib can be increased when combined with Fluticasone furoate."
            },
            {
                "drugbank-id": "DB13867",
                "name": "Fluticasone",
                "description": "The metabolism of Alpelisib can be increased when combined with Fluticasone."
            },
            {
                "drugbank-id": "DB14568",
                "name": "Ivosidenib",
                "description": "The metabolism of Alpelisib can be increased when combined with Ivosidenib."
            },
            {
                "drugbank-id": "DB00741",
                "name": "Hydrocortisone",
                "description": "The metabolism of Alpelisib can be increased when combined with Hydrocortisone."
            },
            {
                "drugbank-id": "DB06636",
                "name": "Isavuconazonium",
                "description": "The metabolism of Alpelisib can be increased when combined with Isavuconazonium."
            },
            {
                "drugbank-id": "DB01013",
                "name": "Clobetasol propionate",
                "description": "The metabolism of Alpelisib can be increased when combined with Clobetasol propionate."
            },
            {
                "drugbank-id": "DB01047",
                "name": "Fluocinonide",
                "description": "The metabolism of Alpelisib can be increased when combined with Fluocinonide."
            },
            {
                "drugbank-id": "DB14540",
                "name": "Hydrocortisone butyrate",
                "description": "The metabolism of Alpelisib can be increased when combined with Hydrocortisone butyrate."
            },
            {
                "drugbank-id": "DB00764",
                "name": "Mometasone",
                "description": "The metabolism of Alpelisib can be increased when combined with Mometasone."
            },
            {
                "drugbank-id": "DB08971",
                "name": "Fluocortolone",
                "description": "The metabolism of Alpelisib can be increased when combined with Fluocortolone."
            },
            {
                "drugbank-id": "DB15566",
                "name": "Prednisolone acetate",
                "description": "The metabolism of Alpelisib can be increased when combined with Prednisolone acetate."
            },
            {
                "drugbank-id": "DB09095",
                "name": "Difluocortolone",
                "description": "The metabolism of Alpelisib can be increased when combined with Difluocortolone."
            },
            {
                "drugbank-id": "DB04896",
                "name": "Milnacipran",
                "description": "The metabolism of Milnacipran can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08918",
                "name": "Levomilnacipran",
                "description": "The metabolism of Levomilnacipran can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00246",
                "name": "Ziprasidone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ziprasidone."
            },
            {
                "drugbank-id": "DB00951",
                "name": "Isoniazid",
                "description": "The metabolism of Alpelisib can be decreased when combined with Isoniazid."
            },
            {
                "drugbank-id": "DB06700",
                "name": "Desvenlafaxine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Desvenlafaxine."
            },
            {
                "drugbank-id": "DB06712",
                "name": "Nilvadipine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Nilvadipine."
            },
            {
                "drugbank-id": "DB06731",
                "name": "Seproxetine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Seproxetine."
            },
            {
                "drugbank-id": "DB08953",
                "name": "Indalpine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Indalpine."
            },
            {
                "drugbank-id": "DB09227",
                "name": "Barnidipine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Barnidipine."
            },
            {
                "drugbank-id": "DB09231",
                "name": "Benidipine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Benidipine."
            },
            {
                "drugbank-id": "DB14019",
                "name": "Fosnetupitant",
                "description": "The metabolism of Alpelisib can be decreased when combined with Fosnetupitant."
            },
            {
                "drugbank-id": "DB00673",
                "name": "Aprepitant",
                "description": "The metabolism of Alpelisib can be decreased when combined with Aprepitant."
            },
            {
                "drugbank-id": "DB08882",
                "name": "Linagliptin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Linagliptin."
            },
            {
                "drugbank-id": "DB00176",
                "name": "Fluvoxamine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Fluvoxamine."
            },
            {
                "drugbank-id": "DB00622",
                "name": "Nicardipine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Nicardipine."
            },
            {
                "drugbank-id": "DB00196",
                "name": "Fluconazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Fluconazole."
            },
            {
                "drugbank-id": "DB00199",
                "name": "Erythromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Erythromycin."
            },
            {
                "drugbank-id": "DB00270",
                "name": "Isradipine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Isradipine."
            },
            {
                "drugbank-id": "DB00537",
                "name": "Ciprofloxacin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ciprofloxacin."
            },
            {
                "drugbank-id": "DB01087",
                "name": "Primaquine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Primaquine."
            },
            {
                "drugbank-id": "DB01110",
                "name": "Miconazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Miconazole."
            },
            {
                "drugbank-id": "DB04832",
                "name": "Zimelidine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Zimelidine."
            },
            {
                "drugbank-id": "DB04839",
                "name": "Cyproterone acetate",
                "description": "The metabolism of Alpelisib can be decreased when combined with Cyproterone acetate."
            },
            {
                "drugbank-id": "DB01369",
                "name": "Quinupristin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Quinupristin."
            },
            {
                "drugbank-id": "DB01764",
                "name": "Dalfopristin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Dalfopristin."
            },
            {
                "drugbank-id": "DB04894",
                "name": "Vapreotide",
                "description": "The metabolism of Alpelisib can be decreased when combined with Vapreotide."
            },
            {
                "drugbank-id": "DB06663",
                "name": "Pasireotide",
                "description": "The metabolism of Alpelisib can be decreased when combined with Pasireotide."
            },
            {
                "drugbank-id": "DB06791",
                "name": "Lanreotide",
                "description": "The metabolism of Alpelisib can be decreased when combined with Lanreotide."
            },
            {
                "drugbank-id": "DB00370",
                "name": "Mirtazapine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Mirtazapine."
            },
            {
                "drugbank-id": "DB00778",
                "name": "Roxithromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Roxithromycin."
            },
            {
                "drugbank-id": "DB01173",
                "name": "Orphenadrine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Orphenadrine."
            },
            {
                "drugbank-id": "DB04884",
                "name": "Dapoxetine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Dapoxetine."
            },
            {
                "drugbank-id": "DB09238",
                "name": "Manidipine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Manidipine."
            },
            {
                "drugbank-id": "DB09063",
                "name": "Ceritinib",
                "description": "The metabolism of Ceritinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00501",
                "name": "Cimetidine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Cimetidine."
            },
            {
                "drugbank-id": "DB01128",
                "name": "Bicalutamide",
                "description": "The metabolism of Bicalutamide can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01259",
                "name": "Lapatinib",
                "description": "The metabolism of Alpelisib can be decreased when combined with Lapatinib."
            },
            {
                "drugbank-id": "DB06589",
                "name": "Pazopanib",
                "description": "The metabolism of Pazopanib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08820",
                "name": "Ivacaftor",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ivacaftor."
            },
            {
                "drugbank-id": "DB09099",
                "name": "Somatostatin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Somatostatin."
            },
            {
                "drugbank-id": "DB11837",
                "name": "Osilodrostat",
                "description": "The metabolism of Alpelisib can be decreased when combined with Osilodrostat."
            },
            {
                "drugbank-id": "DB04794",
                "name": "Bifonazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Bifonazole."
            },
            {
                "drugbank-id": "DB00248",
                "name": "Cabergoline",
                "description": "The metabolism of Cabergoline can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB05773",
                "name": "Trastuzumab emtansine",
                "description": "The metabolism of Trastuzumab emtansine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB14761",
                "name": "Remdesivir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Remdesivir."
            },
            {
                "drugbank-id": "DB01381",
                "name": "Ginkgo biloba",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ginkgo biloba."
            },
            {
                "drugbank-id": "DB00773",
                "name": "Etoposide",
                "description": "The metabolism of Etoposide can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00330",
                "name": "Ethambutol",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ethambutol."
            },
            {
                "drugbank-id": "DB00041",
                "name": "Aldesleukin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Aldesleukin."
            },
            {
                "drugbank-id": "DB00353",
                "name": "Methylergometrine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Methylergometrine."
            },
            {
                "drugbank-id": "DB00446",
                "name": "Chloramphenicol",
                "description": "The metabolism of Alpelisib can be decreased when combined with Chloramphenicol."
            },
            {
                "drugbank-id": "DB00627",
                "name": "Niacin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Niacin."
            },
            {
                "drugbank-id": "DB00647",
                "name": "Dextropropoxyphene",
                "description": "The metabolism of Alpelisib can be decreased when combined with Dextropropoxyphene."
            },
            {
                "drugbank-id": "DB00668",
                "name": "Epinephrine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Epinephrine."
            },
            {
                "drugbank-id": "DB00819",
                "name": "Acetazolamide",
                "description": "The metabolism of Alpelisib can be decreased when combined with Acetazolamide."
            },
            {
                "drugbank-id": "DB00954",
                "name": "Dirithromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Dirithromycin."
            },
            {
                "drugbank-id": "DB01062",
                "name": "Oxybutynin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Oxybutynin."
            },
            {
                "drugbank-id": "DB01071",
                "name": "Mequitazine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Mequitazine."
            },
            {
                "drugbank-id": "DB01152",
                "name": "Candicidin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Candicidin."
            },
            {
                "drugbank-id": "DB01275",
                "name": "Hydralazine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Hydralazine."
            },
            {
                "drugbank-id": "DB01873",
                "name": "Epothilone D",
                "description": "The metabolism of Alpelisib can be decreased when combined with Epothilone D."
            },
            {
                "drugbank-id": "DB02709",
                "name": "Resveratrol",
                "description": "The metabolism of Alpelisib can be decreased when combined with Resveratrol."
            },
            {
                "drugbank-id": "DB03010",
                "name": "Patupilone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Patupilone."
            },
            {
                "drugbank-id": "DB04070",
                "name": "6-Deoxyerythronolide B",
                "description": "The metabolism of Alpelisib can be decreased when combined with 6-Deoxyerythronolide B."
            },
            {
                "drugbank-id": "DB05482",
                "name": "7-ethyl-10-hydroxycamptothecin",
                "description": "The metabolism of Alpelisib can be decreased when combined with 7-ethyl-10-hydroxycamptothecin."
            },
            {
                "drugbank-id": "DB05814",
                "name": "GPI-1485",
                "description": "The metabolism of Alpelisib can be decreased when combined with GPI-1485."
            },
            {
                "drugbank-id": "DB05903",
                "name": "KOS-1584",
                "description": "The metabolism of Alpelisib can be decreased when combined with KOS-1584."
            },
            {
                "drugbank-id": "DB06174",
                "name": "Noscapine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Noscapine."
            },
            {
                "drugbank-id": "DB06233",
                "name": "Ridaforolimus",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ridaforolimus."
            },
            {
                "drugbank-id": "DB06318",
                "name": "AVE9633",
                "description": "The metabolism of Alpelisib can be decreased when combined with AVE9633."
            },
            {
                "drugbank-id": "DB06342",
                "name": "Coltuximab ravtansine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Coltuximab ravtansine."
            },
            {
                "drugbank-id": "DB06419",
                "name": "Cethromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Cethromycin."
            },
            {
                "drugbank-id": "DB06458",
                "name": "Remacemide",
                "description": "The metabolism of Alpelisib can be decreased when combined with Remacemide."
            },
            {
                "drugbank-id": "DB06469",
                "name": "Lestaurtinib",
                "description": "The metabolism of Alpelisib can be decreased when combined with Lestaurtinib."
            },
            {
                "drugbank-id": "DB06587",
                "name": "Mitemcinal",
                "description": "The metabolism of Alpelisib can be decreased when combined with Mitemcinal."
            },
            {
                "drugbank-id": "DB06774",
                "name": "Capsaicin",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Capsaicin."
            },
            {
                "drugbank-id": "DB09235",
                "name": "Efonidipine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Efonidipine."
            },
            {
                "drugbank-id": "DB09308",
                "name": "Solithromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Solithromycin."
            },
            {
                "drugbank-id": "DB09309",
                "name": "Kitasamycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Kitasamycin."
            },
            {
                "drugbank-id": "DB11383",
                "name": "Carbomycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Carbomycin."
            },
            {
                "drugbank-id": "DB11400",
                "name": "Doramectin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Doramectin."
            },
            {
                "drugbank-id": "DB11405",
                "name": "Eprinomectin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Eprinomectin."
            },
            {
                "drugbank-id": "DB11442",
                "name": "Oleandomycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Oleandomycin."
            },
            {
                "drugbank-id": "DB11459",
                "name": "Selamectin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Selamectin."
            },
            {
                "drugbank-id": "DB11470",
                "name": "Tildipirosin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Tildipirosin."
            },
            {
                "drugbank-id": "DB11752",
                "name": "Bryostatin 1",
                "description": "The metabolism of Alpelisib can be decreased when combined with Bryostatin 1."
            },
            {
                "drugbank-id": "DB11805",
                "name": "Saracatinib",
                "description": "The metabolism of Alpelisib can be decreased when combined with Saracatinib."
            },
            {
                "drugbank-id": "DB12089",
                "name": "Lorvotuzumab mertansine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Lorvotuzumab mertansine."
            },
            {
                "drugbank-id": "DB12266",
                "name": "Epofolate",
                "description": "The metabolism of Alpelisib can be decreased when combined with Epofolate."
            },
            {
                "drugbank-id": "DB12391",
                "name": "Sagopilone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Sagopilone."
            },
            {
                "drugbank-id": "DB13287",
                "name": "Miocamycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Miocamycin."
            },
            {
                "drugbank-id": "DB13338",
                "name": "Flurithromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Flurithromycin."
            },
            {
                "drugbank-id": "DB13409",
                "name": "Rokitamycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Rokitamycin."
            },
            {
                "drugbank-id": "DB13456",
                "name": "Midecamycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Midecamycin."
            },
            {
                "drugbank-id": "DB13950",
                "name": "WIN 55212-2",
                "description": "The metabolism of Alpelisib can be decreased when combined with WIN 55212-2."
            },
            {
                "drugbank-id": "DB01093",
                "name": "Dimethyl sulfoxide",
                "description": "The metabolism of Alpelisib can be decreased when combined with Dimethyl sulfoxide."
            },
            {
                "drugbank-id": "DB14635",
                "name": "Curcumin sulfate",
                "description": "The metabolism of Alpelisib can be decreased when combined with Curcumin sulfate."
            },
            {
                "drugbank-id": "DB00444",
                "name": "Teniposide",
                "description": "The metabolism of Teniposide can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00481",
                "name": "Raloxifene",
                "description": "The metabolism of Alpelisib can be decreased when combined with Raloxifene."
            },
            {
                "drugbank-id": "DB00588",
                "name": "Fluticasone propionate",
                "description": "The metabolism of Alpelisib can be decreased when combined with Fluticasone propionate."
            },
            {
                "drugbank-id": "DB00759",
                "name": "Tetracycline",
                "description": "The metabolism of Alpelisib can be decreased when combined with Tetracycline."
            },
            {
                "drugbank-id": "DB00916",
                "name": "Metronidazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Metronidazole."
            },
            {
                "drugbank-id": "DB01388",
                "name": "Mibefradil",
                "description": "The metabolism of Alpelisib can be decreased when combined with Mibefradil."
            },
            {
                "drugbank-id": "DB01587",
                "name": "Ketazolam",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ketazolam."
            },
            {
                "drugbank-id": "DB06616",
                "name": "Bosutinib",
                "description": "The metabolism of Bosutinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB07348",
                "name": "Brefeldin A",
                "description": "The metabolism of Alpelisib can be decreased when combined with Brefeldin A."
            },
            {
                "drugbank-id": "DB08870",
                "name": "Brentuximab vedotin",
                "description": "The metabolism of Brentuximab vedotin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09241",
                "name": "Methylene blue",
                "description": "The metabolism of Alpelisib can be decreased when combined with Methylene blue."
            },
            {
                "drugbank-id": "DB00320",
                "name": "Dihydroergotamine",
                "description": "The metabolism of Dihydroergotamine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08816",
                "name": "Ticagrelor",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ticagrelor."
            },
            {
                "drugbank-id": "DB00637",
                "name": "Astemizole",
                "description": "The metabolism of Astemizole can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01151",
                "name": "Desipramine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Desipramine."
            },
            {
                "drugbank-id": "DB00694",
                "name": "Daunorubicin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Daunorubicin."
            },
            {
                "drugbank-id": "DB08995",
                "name": "Diosmin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Diosmin."
            },
            {
                "drugbank-id": "DB01319",
                "name": "Fosamprenavir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Fosamprenavir."
            },
            {
                "drugbank-id": "DB05667",
                "name": "Levoketoconazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Levoketoconazole."
            },
            {
                "drugbank-id": "DB00717",
                "name": "Norethisterone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Norethisterone."
            },
            {
                "drugbank-id": "DB01395",
                "name": "Drospirenone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Drospirenone."
            },
            {
                "drugbank-id": "DB00567",
                "name": "Cephalexin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Cephalexin."
            },
            {
                "drugbank-id": "DB01431",
                "name": "Allylestrenol",
                "description": "The metabolism of Alpelisib can be decreased when combined with Allylestrenol."
            },
            {
                "drugbank-id": "DB01624",
                "name": "Zuclopenthixol",
                "description": "The metabolism of Alpelisib can be decreased when combined with Zuclopenthixol."
            },
            {
                "drugbank-id": "DB01656",
                "name": "Roflumilast",
                "description": "The serum concentration of Roflumilast can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09071",
                "name": "Tasimelteon",
                "description": "The metabolism of Alpelisib can be decreased when combined with Tasimelteon."
            },
            {
                "drugbank-id": "DB11273",
                "name": "Dihydroergocornine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Dihydroergocornine."
            },
            {
                "drugbank-id": "DB12515",
                "name": "9-aminocamptothecin",
                "description": "The metabolism of Alpelisib can be decreased when combined with 9-aminocamptothecin."
            },
            {
                "drugbank-id": "DB12952",
                "name": "Methylprednisone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Methylprednisone."
            },
            {
                "drugbank-id": "DB13345",
                "name": "Dihydroergocristine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Dihydroergocristine."
            },
            {
                "drugbank-id": "DB13385",
                "name": "Dihydroergocryptine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Dihydroergocryptine."
            },
            {
                "drugbank-id": "DB15444",
                "name": "Elexacaftor",
                "description": "The metabolism of Alpelisib can be decreased when combined with Elexacaftor."
            },
            {
                "drugbank-id": "DB00207",
                "name": "Azithromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Azithromycin."
            },
            {
                "drugbank-id": "DB00518",
                "name": "Albendazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Albendazole."
            },
            {
                "drugbank-id": "DB01039",
                "name": "Fenofibrate",
                "description": "The metabolism of Alpelisib can be decreased when combined with Fenofibrate."
            },
            {
                "drugbank-id": "DB09030",
                "name": "Vorapaxar",
                "description": "The metabolism of Alpelisib can be decreased when combined with Vorapaxar."
            },
            {
                "drugbank-id": "DB09034",
                "name": "Suvorexant",
                "description": "The metabolism of Alpelisib can be decreased when combined with Suvorexant."
            },
            {
                "drugbank-id": "DB09079",
                "name": "Nintedanib",
                "description": "The metabolism of Alpelisib can be decreased when combined with Nintedanib."
            },
            {
                "drugbank-id": "DB09299",
                "name": "Tenofovir alafenamide",
                "description": "The metabolism of Alpelisib can be decreased when combined with Tenofovir alafenamide."
            },
            {
                "drugbank-id": "DB11952",
                "name": "Duvelisib",
                "description": "The metabolism of Alpelisib can be decreased when combined with Duvelisib."
            },
            {
                "drugbank-id": "DB12887",
                "name": "Tazemetostat",
                "description": "The metabolism of Alpelisib can be decreased when combined with Tazemetostat."
            },
            {
                "drugbank-id": "DB00247",
                "name": "Methysergide",
                "description": "The metabolism of Alpelisib can be decreased when combined with Methysergide."
            },
            {
                "drugbank-id": "DB11742",
                "name": "Ebastine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ebastine."
            },
            {
                "drugbank-id": "DB00604",
                "name": "Cisapride",
                "description": "The metabolism of Alpelisib can be decreased when combined with Cisapride."
            },
            {
                "drugbank-id": "DB00454",
                "name": "Meperidine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Meperidine."
            },
            {
                "drugbank-id": "DB05154",
                "name": "Pretomanid",
                "description": "The metabolism of Alpelisib can be decreased when combined with Pretomanid."
            },
            {
                "drugbank-id": "DB05316",
                "name": "Pimavanserin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Pimavanserin."
            },
            {
                "drugbank-id": "DB12235",
                "name": "Estetrol",
                "description": "The metabolism of Alpelisib can be decreased when combined with Estetrol."
            },
            {
                "drugbank-id": "DB11886",
                "name": "Infigratinib",
                "description": "The metabolism of Alpelisib can be decreased when combined with Infigratinib."
            },
            {
                "drugbank-id": "DB00359",
                "name": "Sulfadiazine",
                "description": "The metabolism of Sulfadiazine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00799",
                "name": "Tazarotene",
                "description": "The metabolism of Tazarotene can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00912",
                "name": "Repaglinide",
                "description": "The metabolism of Repaglinide can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00918",
                "name": "Almotriptan",
                "description": "The metabolism of Almotriptan can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01218",
                "name": "Halofantrine",
                "description": "The metabolism of Halofantrine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB05229",
                "name": "Beraprost",
                "description": "The metabolism of Beraprost can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06510",
                "name": "Muraglitazar",
                "description": "The metabolism of Muraglitazar can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08922",
                "name": "Perospirone",
                "description": "The metabolism of Perospirone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08931",
                "name": "Riociguat",
                "description": "The metabolism of Riociguat can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09198",
                "name": "Lobeglitazone",
                "description": "The metabolism of Lobeglitazone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09199",
                "name": "Netoglitazone",
                "description": "The metabolism of Netoglitazone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09200",
                "name": "Rivoglitazone",
                "description": "The metabolism of Rivoglitazone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09201",
                "name": "Ciglitazone",
                "description": "The metabolism of Ciglitazone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12781",
                "name": "Balaglitazone",
                "description": "The metabolism of Balaglitazone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01132",
                "name": "Pioglitazone",
                "description": "The metabolism of Pioglitazone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08502",
                "name": "Capravirine",
                "description": "The metabolism of Capravirine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00641",
                "name": "Simvastatin",
                "description": "The metabolism of Simvastatin can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00295",
                "name": "Morphine",
                "description": "The metabolism of Morphine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00608",
                "name": "Chloroquine",
                "description": "The metabolism of Chloroquine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00613",
                "name": "Amodiaquine",
                "description": "The metabolism of Amodiaquine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00688",
                "name": "Mycophenolate mofetil",
                "description": "The metabolism of Mycophenolate mofetil can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01184",
                "name": "Domperidone",
                "description": "The metabolism of Domperidone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01217",
                "name": "Anastrozole",
                "description": "The metabolism of Anastrozole can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01261",
                "name": "Sitagliptin",
                "description": "The metabolism of Sitagliptin can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06670",
                "name": "Odanacatib",
                "description": "The metabolism of Odanacatib can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06770",
                "name": "Benzyl alcohol",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Benzyl alcohol."
            },
            {
                "drugbank-id": "DB09296",
                "name": "Ombitasvir",
                "description": "The metabolism of Ombitasvir can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11362",
                "name": "Selexipag",
                "description": "The metabolism of Selexipag can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11979",
                "name": "Elagolix",
                "description": "The metabolism of Elagolix can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12612",
                "name": "Ozanimod",
                "description": "The metabolism of Ozanimod can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00714",
                "name": "Apomorphine",
                "description": "The metabolism of Apomorphine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01611",
                "name": "Hydroxychloroquine",
                "description": "The metabolism of Hydroxychloroquine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00544",
                "name": "Fluorouracil",
                "description": "The metabolism of Fluorouracil can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09256",
                "name": "Tegafur",
                "description": "The metabolism of Tegafur can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01229",
                "name": "Paclitaxel",
                "description": "The metabolism of Paclitaxel can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00395",
                "name": "Carisoprodol",
                "description": "The metabolism of Carisoprodol can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00679",
                "name": "Thioridazine",
                "description": "The metabolism of Thioridazine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01058",
                "name": "Praziquantel",
                "description": "The metabolism of Praziquantel can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01175",
                "name": "Escitalopram",
                "description": "The metabolism of Escitalopram can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB05246",
                "name": "Methsuximide",
                "description": "The metabolism of Methsuximide can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB05351",
                "name": "Dexlansoprazole",
                "description": "The metabolism of Dexlansoprazole can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09166",
                "name": "Etizolam",
                "description": "The metabolism of Etizolam can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13762",
                "name": "Dexrabeprazole",
                "description": "The metabolism of Dexrabeprazole can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00598",
                "name": "Labetalol",
                "description": "The metabolism of Labetalol can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04861",
                "name": "Nebivolol",
                "description": "The metabolism of Nebivolol can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06684",
                "name": "Vilazodone",
                "description": "The metabolism of Vilazodone can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00373",
                "name": "Timolol",
                "description": "The metabolism of Timolol can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00571",
                "name": "Propranolol",
                "description": "The metabolism of Propranolol can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00736",
                "name": "Esomeprazole",
                "description": "The metabolism of Esomeprazole can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00909",
                "name": "Zonisamide",
                "description": "The metabolism of Zonisamide can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00665",
                "name": "Nilutamide",
                "description": "The metabolism of Nilutamide can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00738",
                "name": "Pentamidine",
                "description": "The metabolism of Pentamidine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00715",
                "name": "Paroxetine",
                "description": "The metabolism of Paroxetine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01171",
                "name": "Moclobemide",
                "description": "The metabolism of Moclobemide can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00208",
                "name": "Ticlopidine",
                "description": "The metabolism of Ticlopidine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01086",
                "name": "Benzocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Benzocaine."
            },
            {
                "drugbank-id": "DB00458",
                "name": "Imipramine",
                "description": "The metabolism of Imipramine can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00599",
                "name": "Thiopental",
                "description": "The metabolism of Thiopental can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00379",
                "name": "Mexiletine",
                "description": "The metabolism of Mexiletine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00865",
                "name": "Benzphetamine",
                "description": "The metabolism of Benzphetamine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01074",
                "name": "Perhexiline",
                "description": "The metabolism of Perhexiline can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01236",
                "name": "Sevoflurane",
                "description": "The metabolism of Sevoflurane can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01466",
                "name": "Ethylmorphine",
                "description": "The metabolism of Ethylmorphine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01559",
                "name": "Clotiazepam",
                "description": "The metabolism of Clotiazepam can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04871",
                "name": "Lorcaserin",
                "description": "The metabolism of Lorcaserin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04975",
                "name": "Banoxantrone",
                "description": "The metabolism of Banoxantrone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06148",
                "name": "Mianserin",
                "description": "The metabolism of Mianserin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06470",
                "name": "Clomethiazole",
                "description": "The metabolism of Clomethiazole can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06710",
                "name": "Methyltestosterone",
                "description": "The metabolism of Methyltestosterone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00753",
                "name": "Isoflurane",
                "description": "The metabolism of Isoflurane can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13132",
                "name": "Artemisinin",
                "description": "The metabolism of Artemisinin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00835",
                "name": "Brompheniramine",
                "description": "The metabolism of Brompheniramine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00956",
                "name": "Hydrocodone",
                "description": "The metabolism of Hydrocodone can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01069",
                "name": "Promethazine",
                "description": "The metabolism of Promethazine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00751",
                "name": "Epinastine",
                "description": "The metabolism of Epinastine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00574",
                "name": "Fenfluramine",
                "description": "The metabolism of Fenfluramine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00184",
                "name": "Nicotine",
                "description": "The metabolism of Nicotine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09167",
                "name": "Dosulepin",
                "description": "The metabolism of Dosulepin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01101",
                "name": "Capecitabine",
                "description": "The metabolism of Capecitabine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00005",
                "name": "Etanercept",
                "description": "The metabolism of Alpelisib can be increased when combined with Etanercept."
            },
            {
                "drugbank-id": "DB00026",
                "name": "Anakinra",
                "description": "The metabolism of Alpelisib can be increased when combined with Anakinra."
            },
            {
                "drugbank-id": "DB00051",
                "name": "Adalimumab",
                "description": "The metabolism of Alpelisib can be increased when combined with Adalimumab."
            },
            {
                "drugbank-id": "DB00065",
                "name": "Infliximab",
                "description": "The metabolism of Alpelisib can be increased when combined with Infliximab."
            },
            {
                "drugbank-id": "DB01281",
                "name": "Abatacept",
                "description": "The metabolism of Alpelisib can be increased when combined with Abatacept."
            },
            {
                "drugbank-id": "DB04956",
                "name": "Afelimomab",
                "description": "The metabolism of Alpelisib can be increased when combined with Afelimomab."
            },
            {
                "drugbank-id": "DB05676",
                "name": "Apremilast",
                "description": "The metabolism of Alpelisib can be increased when combined with Apremilast."
            },
            {
                "drugbank-id": "DB06168",
                "name": "Canakinumab",
                "description": "The metabolism of Alpelisib can be increased when combined with Canakinumab."
            },
            {
                "drugbank-id": "DB06273",
                "name": "Tocilizumab",
                "description": "The metabolism of Alpelisib can be increased when combined with Tocilizumab."
            },
            {
                "drugbank-id": "DB06372",
                "name": "Rilonacept",
                "description": "The metabolism of Alpelisib can be increased when combined with Rilonacept."
            },
            {
                "drugbank-id": "DB06674",
                "name": "Golimumab",
                "description": "The metabolism of Alpelisib can be increased when combined with Golimumab."
            },
            {
                "drugbank-id": "DB08904",
                "name": "Certolizumab pegol",
                "description": "The metabolism of Alpelisib can be increased when combined with Certolizumab pegol."
            },
            {
                "drugbank-id": "DB09029",
                "name": "Secukinumab",
                "description": "The metabolism of Alpelisib can be increased when combined with Secukinumab."
            },
            {
                "drugbank-id": "DB09036",
                "name": "Siltuximab",
                "description": "The metabolism of Alpelisib can be increased when combined with Siltuximab."
            },
            {
                "drugbank-id": "DB14724",
                "name": "Emapalumab",
                "description": "The metabolism of Alpelisib can be increased when combined with Emapalumab."
            },
            {
                "drugbank-id": "DB06480",
                "name": "Prucalopride",
                "description": "The metabolism of Prucalopride can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00215",
                "name": "Citalopram",
                "description": "Alpelisib may increase the QTc-prolonging activities of Citalopram."
            },
            {
                "drugbank-id": "DB01068",
                "name": "Clonazepam",
                "description": "The metabolism of Clonazepam can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12371",
                "name": "Siponimod",
                "description": "The therapeutic efficacy of Siponimod can be decreased when used in combination with Alpelisib."
            },
            {
                "drugbank-id": "DB12147",
                "name": "Erdafitinib",
                "description": "The metabolism of Erdafitinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00091",
                "name": "Cyclosporine",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Cyclosporine."
            },
            {
                "drugbank-id": "DB00175",
                "name": "Pravastatin",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Pravastatin."
            },
            {
                "drugbank-id": "DB00213",
                "name": "Pantoprazole",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Pantoprazole."
            },
            {
                "drugbank-id": "DB00220",
                "name": "Nelfinavir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Nelfinavir."
            },
            {
                "drugbank-id": "DB00255",
                "name": "Diethylstilbestrol",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Diethylstilbestrol."
            },
            {
                "drugbank-id": "DB00317",
                "name": "Gefitinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Gefitinib."
            },
            {
                "drugbank-id": "DB00338",
                "name": "Omeprazole",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Omeprazole."
            },
            {
                "drugbank-id": "DB00394",
                "name": "Beclomethasone dipropionate",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Beclomethasone dipropionate."
            },
            {
                "drugbank-id": "DB00396",
                "name": "Progesterone",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Progesterone."
            },
            {
                "drugbank-id": "DB00398",
                "name": "Sorafenib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Sorafenib."
            },
            {
                "drugbank-id": "DB00448",
                "name": "Lansoprazole",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Lansoprazole."
            },
            {
                "drugbank-id": "DB00470",
                "name": "Dronabinol",
                "description": "The serum concentration of Dronabinol can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00503",
                "name": "Ritonavir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Ritonavir."
            },
            {
                "drugbank-id": "DB00619",
                "name": "Imatinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Imatinib."
            },
            {
                "drugbank-id": "DB00783",
                "name": "Estradiol",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Estradiol."
            },
            {
                "drugbank-id": "DB00795",
                "name": "Sulfasalazine",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Sulfasalazine."
            },
            {
                "drugbank-id": "DB00921",
                "name": "Buprenorphine",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Buprenorphine."
            },
            {
                "drugbank-id": "DB00966",
                "name": "Telmisartan",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Telmisartan."
            },
            {
                "drugbank-id": "DB01051",
                "name": "Novobiocin",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Novobiocin."
            },
            {
                "drugbank-id": "DB01094",
                "name": "Hesperetin",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Hesperetin."
            },
            {
                "drugbank-id": "DB01129",
                "name": "Rabeprazole",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Rabeprazole."
            },
            {
                "drugbank-id": "DB01232",
                "name": "Saquinavir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Saquinavir."
            },
            {
                "drugbank-id": "DB01254",
                "name": "Dasatinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Dasatinib."
            },
            {
                "drugbank-id": "DB01268",
                "name": "Sunitinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Sunitinib."
            },
            {
                "drugbank-id": "DB01645",
                "name": "Genistein",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Genistein."
            },
            {
                "drugbank-id": "DB01685",
                "name": "Topiroxostat",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Topiroxostat."
            },
            {
                "drugbank-id": "DB02115",
                "name": "Daidzin",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Daidzin."
            },
            {
                "drugbank-id": "DB02703",
                "name": "Fusidic acid",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Fusidic acid."
            },
            {
                "drugbank-id": "DB03467",
                "name": "Naringenin",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Naringenin."
            },
            {
                "drugbank-id": "DB04216",
                "name": "Quercetin",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Quercetin."
            },
            {
                "drugbank-id": "DB04348",
                "name": "Taurocholic acid",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Taurocholic acid."
            },
            {
                "drugbank-id": "DB04868",
                "name": "Nilotinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Nilotinib."
            },
            {
                "drugbank-id": "DB04881",
                "name": "Elacridar",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Elacridar."
            },
            {
                "drugbank-id": "DB05294",
                "name": "Vandetanib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Vandetanib."
            },
            {
                "drugbank-id": "DB05928",
                "name": "Dovitinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Dovitinib."
            },
            {
                "drugbank-id": "DB06210",
                "name": "Eltrombopag",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Eltrombopag."
            },
            {
                "drugbank-id": "DB06290",
                "name": "Simeprevir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Simeprevir."
            },
            {
                "drugbank-id": "DB06654",
                "name": "Safinamide",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Safinamide."
            },
            {
                "drugbank-id": "DB06772",
                "name": "Cabazitaxel",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Cabazitaxel."
            },
            {
                "drugbank-id": "DB08828",
                "name": "Vismodegib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Vismodegib."
            },
            {
                "drugbank-id": "DB08864",
                "name": "Rilpivirine",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Rilpivirine."
            },
            {
                "drugbank-id": "DB08880",
                "name": "Teriflunomide",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Teriflunomide."
            },
            {
                "drugbank-id": "DB08896",
                "name": "Regorafenib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Regorafenib."
            },
            {
                "drugbank-id": "DB08901",
                "name": "Ponatinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Ponatinib."
            },
            {
                "drugbank-id": "DB08912",
                "name": "Dabrafenib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Dabrafenib."
            },
            {
                "drugbank-id": "DB08916",
                "name": "Afatinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Afatinib."
            },
            {
                "drugbank-id": "DB09061",
                "name": "Cannabidiol",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Cannabidiol."
            },
            {
                "drugbank-id": "DB09065",
                "name": "Cobicistat",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Cobicistat."
            },
            {
                "drugbank-id": "DB09073",
                "name": "Palbociclib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Palbociclib."
            },
            {
                "drugbank-id": "DB09074",
                "name": "Olaparib",
                "description": "The metabolism of Olaparib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09102",
                "name": "Daclatasvir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Daclatasvir."
            },
            {
                "drugbank-id": "DB09183",
                "name": "Dasabuvir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Dasabuvir."
            },
            {
                "drugbank-id": "DB09291",
                "name": "Rolapitant",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Rolapitant."
            },
            {
                "drugbank-id": "DB09297",
                "name": "Paritaprevir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Paritaprevir."
            },
            {
                "drugbank-id": "DB11363",
                "name": "Alectinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Alectinib."
            },
            {
                "drugbank-id": "DB11581",
                "name": "Venetoclax",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Venetoclax."
            },
            {
                "drugbank-id": "DB11613",
                "name": "Velpatasvir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Velpatasvir."
            },
            {
                "drugbank-id": "DB11963",
                "name": "Dacomitinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Dacomitinib."
            },
            {
                "drugbank-id": "DB11978",
                "name": "Glasdegib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Glasdegib."
            },
            {
                "drugbank-id": "DB11995",
                "name": "Avatrombopag",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Avatrombopag."
            },
            {
                "drugbank-id": "DB12001",
                "name": "Abemaciclib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Abemaciclib."
            },
            {
                "drugbank-id": "DB12010",
                "name": "Fostamatinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Fostamatinib."
            },
            {
                "drugbank-id": "DB12026",
                "name": "Voxilaprevir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Voxilaprevir."
            },
            {
                "drugbank-id": "DB12070",
                "name": "Letermovir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Letermovir."
            },
            {
                "drugbank-id": "DB12141",
                "name": "Gilteritinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Gilteritinib."
            },
            {
                "drugbank-id": "DB12267",
                "name": "Brigatinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Brigatinib."
            },
            {
                "drugbank-id": "DB12332",
                "name": "Rucaparib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Rucaparib."
            },
            {
                "drugbank-id": "DB13874",
                "name": "Enasidenib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Enasidenib."
            },
            {
                "drugbank-id": "DB13878",
                "name": "Pibrentasvir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Pibrentasvir."
            },
            {
                "drugbank-id": "DB13879",
                "name": "Glecaprevir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Glecaprevir."
            },
            {
                "drugbank-id": "DB13952",
                "name": "Estradiol acetate",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Estradiol acetate."
            },
            {
                "drugbank-id": "DB13953",
                "name": "Estradiol benzoate",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Estradiol benzoate."
            },
            {
                "drugbank-id": "DB13954",
                "name": "Estradiol cypionate",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Estradiol cypionate."
            },
            {
                "drugbank-id": "DB13955",
                "name": "Estradiol dienanthate",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Estradiol dienanthate."
            },
            {
                "drugbank-id": "DB13956",
                "name": "Estradiol valerate",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Estradiol valerate."
            },
            {
                "drugbank-id": "DB14009",
                "name": "Medical Cannabis",
                "description": "The serum concentration of Medical Cannabis can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB14011",
                "name": "Nabiximols",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Nabiximols."
            },
            {
                "drugbank-id": "DB12500",
                "name": "Fedratinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Fedratinib."
            },
            {
                "drugbank-id": "DB11757",
                "name": "Istradefylline",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Istradefylline."
            },
            {
                "drugbank-id": "DB00201",
                "name": "Caffeine",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Caffeine."
            },
            {
                "drugbank-id": "DB08881",
                "name": "Vemurafenib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Vemurafenib."
            },
            {
                "drugbank-id": "DB00845",
                "name": "Clofazimine",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Clofazimine."
            },
            {
                "drugbank-id": "DB11633",
                "name": "Isavuconazole",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Isavuconazole."
            },
            {
                "drugbank-id": "DB14840",
                "name": "Ripretinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Ripretinib."
            },
            {
                "drugbank-id": "DB11796",
                "name": "Fostemsavir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Fostemsavir."
            },
            {
                "drugbank-id": "DB15822",
                "name": "Pralsetinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Pralsetinib."
            },
            {
                "drugbank-id": "DB09330",
                "name": "Osimertinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Osimertinib."
            },
            {
                "drugbank-id": "DB14649",
                "name": "Dexamethasone acetate",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Dexamethasone acetate."
            },
            {
                "drugbank-id": "DB04854",
                "name": "Febuxostat",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Febuxostat."
            },
            {
                "drugbank-id": "DB06237",
                "name": "Avanafil",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Avanafil."
            },
            {
                "drugbank-id": "DB15133",
                "name": "Tepotinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Tepotinib."
            },
            {
                "drugbank-id": "DB16703",
                "name": "Belumosudil",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Belumosudil."
            },
            {
                "drugbank-id": "DB00957",
                "name": "Norgestimate",
                "description": "The serum concentration of Norgestimate can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00238",
                "name": "Nevirapine",
                "description": "The serum concentration of Nevirapine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00661",
                "name": "Verapamil",
                "description": "The serum concentration of Verapamil can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00977",
                "name": "Ethinylestradiol",
                "description": "The serum concentration of Ethinylestradiol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00177",
                "name": "Valsartan",
                "description": "The serum concentration of Valsartan can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00188",
                "name": "Bortezomib",
                "description": "The serum concentration of Bortezomib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00197",
                "name": "Troglitazone",
                "description": "The serum concentration of Troglitazone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00203",
                "name": "Sildenafil",
                "description": "The serum concentration of Sildenafil can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00214",
                "name": "Torasemide",
                "description": "The serum concentration of Torasemide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00216",
                "name": "Eletriptan",
                "description": "The serum concentration of Eletriptan can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00222",
                "name": "Glimepiride",
                "description": "The serum concentration of Glimepiride can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00250",
                "name": "Dapsone",
                "description": "The serum concentration of Dapsone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00266",
                "name": "Dicoumarol",
                "description": "The serum concentration of Dicoumarol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00285",
                "name": "Venlafaxine",
                "description": "Venlafaxine may increase the excretion rate of Alpelisib which could result in a lower serum level and potentially a reduction in efficacy."
            },
            {
                "drugbank-id": "DB00304",
                "name": "Desogestrel",
                "description": "The serum concentration of Desogestrel can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00307",
                "name": "Bexarotene",
                "description": "The serum concentration of Bexarotene can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00313",
                "name": "Valproic acid",
                "description": "The serum concentration of Valproic acid can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00321",
                "name": "Amitriptyline",
                "description": "The serum concentration of Amitriptyline can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00327",
                "name": "Hydromorphone",
                "description": "The serum concentration of Hydromorphone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00328",
                "name": "Indomethacin",
                "description": "The serum concentration of Indomethacin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00333",
                "name": "Methadone",
                "description": "The serum concentration of Methadone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00343",
                "name": "Diltiazem",
                "description": "The serum concentration of Diltiazem can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00347",
                "name": "Trimethadione",
                "description": "The serum concentration of Trimethadione can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00363",
                "name": "Clozapine",
                "description": "The serum concentration of Clozapine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00374",
                "name": "Treprostinil",
                "description": "The serum concentration of Treprostinil can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00412",
                "name": "Rosiglitazone",
                "description": "The serum concentration of Rosiglitazone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00414",
                "name": "Acetohexamide",
                "description": "The serum concentration of Acetohexamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00420",
                "name": "Promazine",
                "description": "The serum concentration of Promazine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00425",
                "name": "Zolpidem",
                "description": "The serum concentration of Zolpidem can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00440",
                "name": "Trimethoprim",
                "description": "The serum concentration of Trimethoprim can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00461",
                "name": "Nabumetone",
                "description": "The serum concentration of Nabumetone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00468",
                "name": "Quinine",
                "description": "The serum concentration of Quinine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00469",
                "name": "Tenoxicam",
                "description": "The serum concentration of Tenoxicam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00471",
                "name": "Montelukast",
                "description": "The serum concentration of Montelukast can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00472",
                "name": "Fluoxetine",
                "description": "The serum concentration of Fluoxetine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00476",
                "name": "Duloxetine",
                "description": "The serum concentration of Duloxetine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00482",
                "name": "Celecoxib",
                "description": "The serum concentration of Celecoxib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00495",
                "name": "Zidovudine",
                "description": "The serum concentration of Zidovudine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00514",
                "name": "Dextromethorphan",
                "description": "The serum concentration of Dextromethorphan can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00531",
                "name": "Cyclophosphamide",
                "description": "The serum concentration of Cyclophosphamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00532",
                "name": "Mephenytoin",
                "description": "The serum concentration of Mephenytoin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00533",
                "name": "Rofecoxib",
                "description": "The serum concentration of Rofecoxib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00549",
                "name": "Zafirlukast",
                "description": "The serum concentration of Zafirlukast can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00554",
                "name": "Piroxicam",
                "description": "The serum concentration of Piroxicam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00559",
                "name": "Bosentan",
                "description": "The serum concentration of Bosentan can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00568",
                "name": "Cinnarizine",
                "description": "The serum concentration of Cinnarizine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00580",
                "name": "Valdecoxib",
                "description": "The serum concentration of Valdecoxib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00582",
                "name": "Voriconazole",
                "description": "The serum concentration of Voriconazole can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00586",
                "name": "Diclofenac",
                "description": "The serum concentration of Diclofenac can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00590",
                "name": "Doxazosin",
                "description": "The serum concentration of Doxazosin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00617",
                "name": "Paramethadione",
                "description": "The serum concentration of Paramethadione can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00624",
                "name": "Testosterone",
                "description": "The serum concentration of Testosterone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00672",
                "name": "Chlorpropamide",
                "description": "The serum concentration of Chlorpropamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00675",
                "name": "Tamoxifen",
                "description": "The serum concentration of Tamoxifen can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00678",
                "name": "Losartan",
                "description": "The serum concentration of Losartan can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00701",
                "name": "Amprenavir",
                "description": "The serum concentration of Amprenavir can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00712",
                "name": "Flurbiprofen",
                "description": "The serum concentration of Flurbiprofen can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00726",
                "name": "Trimipramine",
                "description": "The serum concentration of Trimipramine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00731",
                "name": "Nateglinide",
                "description": "The serum concentration of Nateglinide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00744",
                "name": "Zileuton",
                "description": "The serum concentration of Zileuton can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00749",
                "name": "Etodolac",
                "description": "The serum concentration of Etodolac can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00755",
                "name": "Tretinoin",
                "description": "The serum concentration of Tretinoin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00758",
                "name": "Clopidogrel",
                "description": "The serum concentration of Clopidogrel can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00784",
                "name": "Mefenamic acid",
                "description": "The serum concentration of Mefenamic acid can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00788",
                "name": "Naproxen",
                "description": "The serum concentration of Naproxen can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00796",
                "name": "Candesartan cilexetil",
                "description": "The serum concentration of Candesartan cilexetil can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00812",
                "name": "Phenylbutazone",
                "description": "The serum concentration of Phenylbutazone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00814",
                "name": "Meloxicam",
                "description": "The serum concentration of Meloxicam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00818",
                "name": "Propofol",
                "description": "The serum concentration of Propofol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00829",
                "name": "Diazepam",
                "description": "The serum concentration of Diazepam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00839",
                "name": "Tolazamide",
                "description": "The serum concentration of Tolazamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00843",
                "name": "Donepezil",
                "description": "The serum concentration of Donepezil can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00857",
                "name": "Terbinafine",
                "description": "The serum concentration of Terbinafine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00904",
                "name": "Ondansetron",
                "description": "The serum concentration of Ondansetron can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00936",
                "name": "Salicylic acid",
                "description": "The serum concentration of Salicylic acid can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00945",
                "name": "Acetylsalicylic acid",
                "description": "The serum concentration of Acetylsalicylic acid can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00946",
                "name": "Phenprocoumon",
                "description": "The serum concentration of Phenprocoumon can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00969",
                "name": "Alosetron",
                "description": "The serum concentration of Alosetron can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00972",
                "name": "Azelastine",
                "description": "The serum concentration of Azelastine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00980",
                "name": "Ramelteon",
                "description": "The serum concentration of Ramelteon can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00983",
                "name": "Formoterol",
                "description": "The serum concentration of Formoterol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01015",
                "name": "Sulfamethoxazole",
                "description": "The serum concentration of Sulfamethoxazole can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01016",
                "name": "Glyburide",
                "description": "The serum concentration of Glyburide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01028",
                "name": "Methoxyflurane",
                "description": "The serum concentration of Methoxyflurane can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01029",
                "name": "Irbesartan",
                "description": "The serum concentration of Irbesartan can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01036",
                "name": "Tolterodine",
                "description": "The serum concentration of Tolterodine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01037",
                "name": "Selegiline",
                "description": "The serum concentration of Selegiline can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01041",
                "name": "Thalidomide",
                "description": "The serum concentration of Thalidomide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01050",
                "name": "Ibuprofen",
                "description": "The serum concentration of Ibuprofen can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01067",
                "name": "Glipizide",
                "description": "The serum concentration of Glipizide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01072",
                "name": "Atazanavir",
                "description": "The serum concentration of Atazanavir can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01075",
                "name": "Diphenhydramine",
                "description": "The serum concentration of Diphenhydramine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01095",
                "name": "Fluvastatin",
                "description": "The serum concentration of Fluvastatin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01097",
                "name": "Leflunomide",
                "description": "The serum concentration of Leflunomide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01098",
                "name": "Rosuvastatin",
                "description": "The serum concentration of Rosuvastatin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01104",
                "name": "Sertraline",
                "description": "The serum concentration of Sertraline can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01120",
                "name": "Gliclazide",
                "description": "The serum concentration of Gliclazide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01124",
                "name": "Tolbutamide",
                "description": "The serum concentration of Tolbutamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01131",
                "name": "Proguanil",
                "description": "The serum concentration of Proguanil can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01136",
                "name": "Carvedilol",
                "description": "The serum concentration of Carvedilol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01142",
                "name": "Doxepin",
                "description": "The serum concentration of Doxepin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01154",
                "name": "Thiamylal",
                "description": "The serum concentration of Thiamylal can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01156",
                "name": "Bupropion",
                "description": "The serum concentration of Bupropion can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01159",
                "name": "Halothane",
                "description": "The serum concentration of Halothane can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01177",
                "name": "Idarubicin",
                "description": "The serum concentration of Idarubicin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01221",
                "name": "Ketamine",
                "description": "The serum concentration of Ketamine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01251",
                "name": "Gliquidone",
                "description": "The serum concentration of Gliquidone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01274",
                "name": "Arformoterol",
                "description": "The serum concentration of Arformoterol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01283",
                "name": "Lumiracoxib",
                "description": "The serum concentration of Lumiracoxib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01289",
                "name": "Glisoxepide",
                "description": "The serum concentration of Glisoxepide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01355",
                "name": "Hexobarbital",
                "description": "The serum concentration of Hexobarbital can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01357",
                "name": "Mestranol",
                "description": "The serum concentration of Mestranol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01424",
                "name": "Aminophenazone",
                "description": "The serum concentration of Aminophenazone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01435",
                "name": "Antipyrine",
                "description": "The serum concentration of Antipyrine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01544",
                "name": "Flunitrazepam",
                "description": "The serum concentration of Flunitrazepam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01589",
                "name": "Quazepam",
                "description": "The serum concentration of Quazepam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01628",
                "name": "Etoricoxib",
                "description": "The serum concentration of Etoricoxib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB03756",
                "name": "Doconexent",
                "description": "The serum concentration of Doconexent can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB03783",
                "name": "Phenacetin",
                "description": "The serum concentration of Phenacetin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04557",
                "name": "Arachidonic Acid",
                "description": "The serum concentration of Arachidonic Acid can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04574",
                "name": "Estrone sulfate",
                "description": "The serum concentration of Estrone sulfate can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04665",
                "name": "Coumarin",
                "description": "The serum concentration of Coumarin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04725",
                "name": "Licofelone",
                "description": "The serum concentration of Licofelone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04841",
                "name": "Flunarizine",
                "description": "The serum concentration of Flunarizine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04898",
                "name": "Ximelagatran",
                "description": "The serum concentration of Ximelagatran can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04938",
                "name": "Ospemifene",
                "description": "The serum concentration of Ospemifene can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB05109",
                "name": "Trabectedin",
                "description": "The serum concentration of Trabectedin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB05541",
                "name": "Brivaracetam",
                "description": "The serum concentration of Brivaracetam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06209",
                "name": "Prasugrel",
                "description": "The serum concentration of Prasugrel can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06218",
                "name": "Lacosamide",
                "description": "The serum concentration of Lacosamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06268",
                "name": "Sitaxentan",
                "description": "The serum concentration of Sitaxentan can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06292",
                "name": "Dapagliflozin",
                "description": "The serum concentration of Dapagliflozin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06370",
                "name": "Indisulam",
                "description": "The serum concentration of Indisulam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06414",
                "name": "Etravirine",
                "description": "The serum concentration of Etravirine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06605",
                "name": "Apixaban",
                "description": "The serum concentration of Apixaban can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06652",
                "name": "Vicriviroc",
                "description": "The serum concentration of Vicriviroc can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06697",
                "name": "Artemether",
                "description": "The serum concentration of Artemether can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06725",
                "name": "Lornoxicam",
                "description": "The serum concentration of Lornoxicam can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06737",
                "name": "Zaltoprofen",
                "description": "The serum concentration of Zaltoprofen can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06738",
                "name": "Ketobemidone",
                "description": "The serum concentration of Ketobemidone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06739",
                "name": "Seratrodast",
                "description": "The serum concentration of Seratrodast can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06803",
                "name": "Niclosamide",
                "description": "The serum concentration of Niclosamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB07615",
                "name": "Tranilast",
                "description": "The serum concentration of Tranilast can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08439",
                "name": "Parecoxib",
                "description": "The serum concentration of Parecoxib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08860",
                "name": "Pitavastatin",
                "description": "The serum concentration of Pitavastatin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08875",
                "name": "Cabozantinib",
                "description": "The serum concentration of Cabozantinib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08962",
                "name": "Glibornuride",
                "description": "The serum concentration of Glibornuride can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09048",
                "name": "Netupitant",
                "description": "The serum concentration of Netupitant can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09068",
                "name": "Vortioxetine",
                "description": "The serum concentration of Vortioxetine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09080",
                "name": "Olodaterol",
                "description": "The serum concentration of Olodaterol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09288",
                "name": "Propacetamol",
                "description": "The serum concentration of Propacetamol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11560",
                "name": "Lesinurad",
                "description": "The serum concentration of Lesinurad can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11586",
                "name": "Asunaprevir",
                "description": "The serum concentration of Asunaprevir can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11614",
                "name": "Rupatadine",
                "description": "The serum concentration of Rupatadine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11823",
                "name": "Esketamine",
                "description": "The serum concentration of Esketamine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12245",
                "name": "Triclabendazole",
                "description": "The serum concentration of Triclabendazole can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12474",
                "name": "Lynestrenol",
                "description": "The serum concentration of Lynestrenol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13136",
                "name": "Fluindione",
                "description": "The serum concentration of Fluindione can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13406",
                "name": "Carbutamide",
                "description": "The serum concentration of Carbutamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13675",
                "name": "Metahexamide",
                "description": "The serum concentration of Metahexamide can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13919",
                "name": "Candesartan",
                "description": "The serum concentration of Candesartan can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13941",
                "name": "Piperaquine",
                "description": "The serum concentration of Piperaquine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13943",
                "name": "Testosterone cypionate",
                "description": "The serum concentration of Testosterone cypionate can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB13944",
                "name": "Testosterone enanthate",
                "description": "The serum concentration of Testosterone enanthate can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01198",
                "name": "Zopiclone",
                "description": "The serum concentration of Zopiclone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00682",
                "name": "Warfarin",
                "description": "The serum concentration of Warfarin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01418",
                "name": "Acenocoumarol",
                "description": "The serum concentration of Acenocoumarol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08496",
                "name": "(R)-warfarin",
                "description": "The serum concentration of (R)-warfarin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB14055",
                "name": "(S)-Warfarin",
                "description": "The serum concentration of (S)-Warfarin can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09213",
                "name": "Dexibuprofen",
                "description": "The serum concentration of Dexibuprofen can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00465",
                "name": "Ketorolac",
                "description": "The serum concentration of Ketorolac can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB15233",
                "name": "Avapritinib",
                "description": "The serum concentration of Avapritinib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11689",
                "name": "Selumetinib",
                "description": "The serum concentration of Selumetinib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08877",
                "name": "Ruxolitinib",
                "description": "The serum concentration of Ruxolitinib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB06448",
                "name": "Lonafarnib",
                "description": "The serum concentration of Lonafarnib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00402",
                "name": "Eszopiclone",
                "description": "The serum concentration of Eszopiclone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11986",
                "name": "Entrectinib",
                "description": "The metabolism of Entrectinib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12825",
                "name": "Lefamulin",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Lefamulin."
            },
            {
                "drugbank-id": "DB04855",
                "name": "Dronedarone",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Dronedarone."
            },
            {
                "drugbank-id": "DB11732",
                "name": "Lasmiditan",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Lasmiditan."
            },
            {
                "drugbank-id": "DB14975",
                "name": "Voxelotor",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Voxelotor."
            },
            {
                "drugbank-id": "DB06119",
                "name": "Cenobamate",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Cenobamate."
            },
            {
                "drugbank-id": "DB09237",
                "name": "Levamlodipine",
                "description": "The serum concentration of Levamlodipine can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11951",
                "name": "Lemborexant",
                "description": "The serum concentration of Lemborexant can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12941",
                "name": "Darolutamide",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Darolutamide."
            },
            {
                "drugbank-id": "DB06077",
                "name": "Lumateperone",
                "description": "The serum concentration of Lumateperone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB15328",
                "name": "Ubrogepant",
                "description": "The serum concentration of Ubrogepant can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00243",
                "name": "Ranolazine",
                "description": "The metabolism of Ranolazine can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11644",
                "name": "Tafamidis",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Tafamidis."
            },
            {
                "drugbank-id": "DB00193",
                "name": "Tramadol",
                "description": "The metabolism of Tramadol can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01190",
                "name": "Clindamycin",
                "description": "The metabolism of Clindamycin can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB12457",
                "name": "Rimegepant",
                "description": "The metabolism of Rimegepant can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01264",
                "name": "Darunavir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Darunavir."
            },
            {
                "drugbank-id": "DB00502",
                "name": "Haloperidol",
                "description": "The serum concentration of Haloperidol can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11652",
                "name": "Tucatinib",
                "description": "The metabolism of Tucatinib can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11791",
                "name": "Capmatinib",
                "description": "The serum concentration of Capmatinib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB15685",
                "name": "Selpercatinib",
                "description": "The serum concentration of Selpercatinib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00104",
                "name": "Octreotide",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Octreotide."
            },
            {
                "drugbank-id": "DB11932",
                "name": "Abametapir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Abametapir."
            },
            {
                "drugbank-id": "DB14881",
                "name": "Oliceridine",
                "description": "The serum concentration of Oliceridine can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB15762",
                "name": "Satralizumab",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Satralizumab."
            },
            {
                "drugbank-id": "DB15982",
                "name": "Berotralstat",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Berotralstat."
            },
            {
                "drugbank-id": "DB11800",
                "name": "Tivozanib",
                "description": "The metabolism of Tivozanib can be increased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB15569",
                "name": "Sotorasib",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Sotorasib."
            },
            {
                "drugbank-id": "DB16165",
                "name": "Finerenone",
                "description": "The serum concentration of Finerenone can be increased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB01406",
                "name": "Danazol",
                "description": "The metabolism of Alpelisib can be decreased when combined with Danazol."
            },
            {
                "drugbank-id": "DB00625",
                "name": "Efavirenz",
                "description": "The metabolism of Alpelisib can be decreased when combined with Efavirenz."
            },
            {
                "drugbank-id": "DB00705",
                "name": "Delavirdine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Delavirdine."
            },
            {
                "drugbank-id": "DB00836",
                "name": "Loperamide",
                "description": "The metabolism of Loperamide can be decreased when combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00976",
                "name": "Telithromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Telithromycin."
            },
            {
                "drugbank-id": "DB01026",
                "name": "Ketoconazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ketoconazole."
            },
            {
                "drugbank-id": "DB01149",
                "name": "Nefazodone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Nefazodone."
            },
            {
                "drugbank-id": "DB01167",
                "name": "Itraconazole",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Itraconazole."
            },
            {
                "drugbank-id": "DB01183",
                "name": "Naloxone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Naloxone."
            },
            {
                "drugbank-id": "DB01211",
                "name": "Clarithromycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Clarithromycin."
            },
            {
                "drugbank-id": "DB01263",
                "name": "Posaconazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Posaconazole."
            },
            {
                "drugbank-id": "DB02520",
                "name": "Ditiocarb",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ditiocarb."
            },
            {
                "drugbank-id": "DB05521",
                "name": "Telaprevir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Telaprevir."
            },
            {
                "drugbank-id": "DB09101",
                "name": "Elvitegravir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Elvitegravir."
            },
            {
                "drugbank-id": "DB09118",
                "name": "Stiripentol",
                "description": "The metabolism of Alpelisib can be decreased when combined with Stiripentol."
            },
            {
                "drugbank-id": "DB11730",
                "name": "Ribociclib",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ribociclib."
            },
            {
                "drugbank-id": "DB11779",
                "name": "Danoprevir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Danoprevir."
            },
            {
                "drugbank-id": "DB13179",
                "name": "Troleandomycin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Troleandomycin."
            },
            {
                "drugbank-id": "DB00763",
                "name": "Methimazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Methimazole."
            },
            {
                "drugbank-id": "DB08873",
                "name": "Boceprevir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Boceprevir."
            },
            {
                "drugbank-id": "DB01601",
                "name": "Lopinavir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Lopinavir."
            },
            {
                "drugbank-id": "DB00696",
                "name": "Ergotamine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Ergotamine."
            },
            {
                "drugbank-id": "DB00872",
                "name": "Conivaptan",
                "description": "The metabolism of Alpelisib can be decreased when combined with Conivaptan."
            },
            {
                "drugbank-id": "DB00932",
                "name": "Tipranavir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Tipranavir."
            },
            {
                "drugbank-id": "DB01118",
                "name": "Amiodarone",
                "description": "The metabolism of Alpelisib can be decreased when combined with Amiodarone."
            },
            {
                "drugbank-id": "DB00342",
                "name": "Terfenadine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Terfenadine."
            },
            {
                "drugbank-id": "DB00224",
                "name": "Indinavir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Indinavir."
            },
            {
                "drugbank-id": "DB00012",
                "name": "Darbepoetin alfa",
                "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00016",
                "name": "Erythropoietin",
                "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB08894",
                "name": "Peginesatide",
                "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB09107",
                "name": "Methoxy polyethylene glycol-epoetin beta",
                "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB00252",
                "name": "Phenytoin",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Phenytoin."
            },
            {
                "drugbank-id": "DB00312",
                "name": "Pentobarbital",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Pentobarbital."
            },
            {
                "drugbank-id": "DB00564",
                "name": "Carbamazepine",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Carbamazepine."
            },
            {
                "drugbank-id": "DB00648",
                "name": "Mitotane",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Mitotane."
            },
            {
                "drugbank-id": "DB00794",
                "name": "Primidone",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Primidone."
            },
            {
                "drugbank-id": "DB01045",
                "name": "Rifampicin",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Rifampicin."
            },
            {
                "drugbank-id": "DB01174",
                "name": "Phenobarbital",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Phenobarbital."
            },
            {
                "drugbank-id": "DB01234",
                "name": "Dexamethasone",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Dexamethasone."
            },
            {
                "drugbank-id": "DB01320",
                "name": "Fosphenytoin",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Fosphenytoin."
            },
            {
                "drugbank-id": "DB01323",
                "name": "St. John's Wort",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with St. John's Wort."
            },
            {
                "drugbank-id": "DB06595",
                "name": "Midostaurin",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Midostaurin."
            },
            {
                "drugbank-id": "DB08899",
                "name": "Enzalutamide",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Enzalutamide."
            },
            {
                "drugbank-id": "DB09280",
                "name": "Lumacaftor",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Lumacaftor."
            },
            {
                "drugbank-id": "DB11753",
                "name": "Rifamycin",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Rifamycin."
            },
            {
                "drugbank-id": "DB11901",
                "name": "Apalutamide",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Apalutamide."
            },
            {
                "drugbank-id": "DB15463",
                "name": "Belzutifan",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Belzutifan."
            },
            {
                "drugbank-id": "DB09027",
                "name": "Ledipasvir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Ledipasvir."
            },
            {
                "drugbank-id": "DB11574",
                "name": "Elbasvir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Elbasvir."
            },
            {
                "drugbank-id": "DB11575",
                "name": "Grazoprevir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Grazoprevir."
            },
            {
                "drugbank-id": "DB12130",
                "name": "Lorlatinib",
                "description": "The metabolism of Alpelisib can be increased when combined with Lorlatinib."
            },
            {
                "drugbank-id": "DB12265",
                "name": "Fexinidazole",
                "description": "The metabolism of Alpelisib can be decreased when combined with Fexinidazole."
            },
            {
                "drugbank-id": "DB11672",
                "name": "Curcumin",
                "description": "The metabolism of Alpelisib can be decreased when combined with Curcumin."
            },
            {
                "drugbank-id": "DB16390",
                "name": "Mobocertinib",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Mobocertinib."
            },
            {
                "drugbank-id": "DB15011",
                "name": "Avacopan",
                "description": "The metabolism of Alpelisib can be decreased when combined with Avacopan."
            },
            {
                "drugbank-id": "DB12597",
                "name": "Asciminib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Asciminib."
            },
            {
                "drugbank-id": "DB06234",
                "name": "Maribavir",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Maribavir."
            },
            {
                "drugbank-id": "DB14960",
                "name": "Somatrogon",
                "description": "The metabolism of Alpelisib can be increased when combined with Somatrogon."
            },
            {
                "drugbank-id": "DB12917",
                "name": "Bimekizumab",
                "description": "The metabolism of Alpelisib can be increased when combined with Bimekizumab."
            },
            {
                "drugbank-id": "DB12713",
                "name": "Sotagliflozin",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Sotagliflozin."
            },
            {
                "drugbank-id": "DB14973",
                "name": "Abrocitinib",
                "description": "The serum concentration of Abrocitinib can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB04847",
                "name": "Roxadustat",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Roxadustat."
            },
            {
                "drugbank-id": "DB16236",
                "name": "Mitapivat",
                "description": "The metabolism of Alpelisib can be increased when combined with Mitapivat."
            },
            {
                "drugbank-id": "DB00486",
                "name": "Nabilone",
                "description": "The serum concentration of Nabilone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB14737",
                "name": "Cannabinol",
                "description": "The serum concentration of Cannabinol can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB11697",
                "name": "Pacritinib",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Pacritinib."
            },
            {
                "drugbank-id": "DB13055",
                "name": "Oteseconazole",
                "description": "The serum concentration of Alpelisib can be increased when it is combined with Oteseconazole."
            },
            {
                "drugbank-id": "DB09185",
                "name": "Viloxazine",
                "description": "The metabolism of Alpelisib can be decreased when combined with Viloxazine."
            },
            {
                "drugbank-id": "DB14921",
                "name": "Mavacamten",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Mavacamten."
            },
            {
                "drugbank-id": "DB15434",
                "name": "Mosunetuzumab",
                "description": "The metabolism of Alpelisib can be decreased when combined with Mosunetuzumab."
            },
            {
                "drugbank-id": "DB12020",
                "name": "Tecovirimat",
                "description": "The metabolism of Alpelisib can be increased when combined with Tecovirimat."
            },
            {
                "drugbank-id": "DB04951",
                "name": "Pirfenidone",
                "description": "The serum concentration of Pirfenidone can be decreased when it is combined with Alpelisib."
            },
            {
                "drugbank-id": "DB15673",
                "name": "Lenacapavir",
                "description": "The metabolism of Alpelisib can be decreased when combined with Lenacapavir."
            },
            {
                "drugbank-id": "DB12095",
                "name": "Telotristat ethyl",
                "description": "The serum concentration of Alpelisib can be decreased when it is combined with Telotristat ethyl."
            },
            {
                "drugbank-id": "DB00281",
                "name": "Lidocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Lidocaine."
            },
            {
                "drugbank-id": "DB00296",
                "name": "Ropivacaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Ropivacaine."
            },
            {
                "drugbank-id": "DB00297",
                "name": "Bupivacaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Bupivacaine."
            },
            {
                "drugbank-id": "DB00527",
                "name": "Cinchocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Cinchocaine."
            },
            {
                "drugbank-id": "DB00645",
                "name": "Dyclonine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Dyclonine."
            },
            {
                "drugbank-id": "DB00721",
                "name": "Procaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Procaine."
            },
            {
                "drugbank-id": "DB00750",
                "name": "Prilocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Prilocaine."
            },
            {
                "drugbank-id": "DB00807",
                "name": "Proparacaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Proparacaine."
            },
            {
                "drugbank-id": "DB00892",
                "name": "Oxybuprocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Oxybuprocaine."
            },
            {
                "drugbank-id": "DB00907",
                "name": "Cocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Cocaine."
            },
            {
                "drugbank-id": "DB00961",
                "name": "Mepivacaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Mepivacaine."
            },
            {
                "drugbank-id": "DB01002",
                "name": "Levobupivacaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Levobupivacaine."
            },
            {
                "drugbank-id": "DB01161",
                "name": "Chloroprocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Chloroprocaine."
            },
            {
                "drugbank-id": "DB03255",
                "name": "Phenol",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Phenol."
            },
            {
                "drugbank-id": "DB05232",
                "name": "Tetrodotoxin",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Tetrodotoxin."
            },
            {
                "drugbank-id": "DB08987",
                "name": "Etidocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Etidocaine."
            },
            {
                "drugbank-id": "DB09009",
                "name": "Articaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Articaine."
            },
            {
                "drugbank-id": "DB09085",
                "name": "Tetracaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Tetracaine."
            },
            {
                "drugbank-id": "DB09342",
                "name": "Propoxycaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Propoxycaine."
            },
            {
                "drugbank-id": "DB09345",
                "name": "Pramocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Pramocaine."
            },
            {
                "drugbank-id": "DB11148",
                "name": "Butamben",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Butamben."
            },
            {
                "drugbank-id": "DB11502",
                "name": "Butacaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Butacaine."
            },
            {
                "drugbank-id": "DB12532",
                "name": "Oxetacaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Oxetacaine."
            },
            {
                "drugbank-id": "DB13259",
                "name": "Ethyl chloride",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Ethyl chloride."
            },
            {
                "drugbank-id": "DB13328",
                "name": "Butanilicaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Butanilicaine."
            },
            {
                "drugbank-id": "DB13578",
                "name": "Metabutethamine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Metabutethamine."
            },
            {
                "drugbank-id": "DB13683",
                "name": "Quinisocaine",
                "description": "The risk or severity of methemoglobinemia can be increased when Alpelisib is combined with Quinisocaine."
            }
        ]
    },
    "calculated-properties": {
        "property": [
            {
                "kind": "logP",
                "value": "2.76",
                "source": "ALOGPS"
            },
            {
                "kind": "logS",
                "value": "-4.9",
                "source": "ALOGPS"
            },
            {
                "kind": "Water Solubility",
                "value": "5.28e-03 g/l",
                "source": "ALOGPS"
            },
            {
                "kind": "logP",
                "value": "2.81",
                "source": "ChemAxon"
            },
            {
                "kind": "IUPAC Name",
                "value": "(2S)-N1-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide",
                "source": "ChemAxon"
            },
            {
                "kind": "Traditional IUPAC Name",
                "value": "alpelisib",
                "source": "ChemAxon"
            },
            {
                "kind": "Molecular Weight",
                "value": "441.47",
                "source": "ChemAxon"
            },
            {
                "kind": "Monoisotopic Weight",
                "value": "441.144630278",
                "source": "ChemAxon"
            },
            {
                "kind": "SMILES",
                "value": "CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F",
                "source": "ChemAxon"
            },
            {
                "kind": "Molecular Formula",
                "value": "C19H22F3N5O2S",
                "source": "ChemAxon"
            },
            {
                "kind": "InChI",
                "value": "InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1",
                "source": "ChemAxon"
            },
            {
                "kind": "InChIKey",
                "value": "STUWGJZDJHPWGZ-LBPRGKRZSA-N",
                "source": "ChemAxon"
            },
            {
                "kind": "Polar Surface Area (PSA)",
                "value": "101.21",
                "source": "ChemAxon"
            },
            {
                "kind": "Refractivity",
                "value": "105.85",
                "source": "ChemAxon"
            },
            {
                "kind": "Polarizability",
                "value": "42.75",
                "source": "ChemAxon"
            },
            {
                "kind": "Rotatable Bond Count",
                "value": "5",
                "source": "ChemAxon"
            },
            {
                "kind": "H Bond Acceptor Count",
                "value": "4",
                "source": "ChemAxon"
            },
            {
                "kind": "H Bond Donor Count",
                "value": "2",
                "source": "ChemAxon"
            },
            {
                "kind": "pKa (strongest acidic)",
                "value": "7.79",
                "source": "ChemAxon"
            },
            {
                "kind": "pKa (strongest basic)",
                "value": "2.81",
                "source": "ChemAxon"
            },
            {
                "kind": "Physiological Charge",
                "value": "0",
                "source": "ChemAxon"
            },
            {
                "kind": "Number of Rings",
                "value": "3",
                "source": "ChemAxon"
            },
            {
                "kind": "Bioavailability",
                "value": "1",
                "source": "ChemAxon"
            },
            {
                "kind": "Rule of Five",
                "value": "1",
                "source": "ChemAxon"
            },
            {
                "kind": "Ghose Filter",
                "value": "1",
                "source": "ChemAxon"
            },
            {
                "kind": "MDDR-Like Rule",
                "value": "0",
                "source": "ChemAxon"
            }
        ]
    },
    "experimental-properties": null,
    "external-identifiers": {
        "external-identifier": [
            {
                "resource": "Drugs Product Database (DPD)",
                "identifier": "23434"
            },
            {
                "resource": "ChEBI",
                "identifier": "93752"
            },
            {
                "resource": "PubChem Compound",
                "identifier": "56649450"
            },
            {
                "resource": "PubChem Substance",
                "identifier": "347828332"
            },
            {
                "resource": "ChemSpider",
                "identifier": "28424123"
            },
            {
                "resource": "BindingDB",
                "identifier": "50436459"
            },
            {
                "resource": "PDB",
                "identifier": "1LT"
            },
            {
                "resource": "Wikipedia",
                "identifier": "Phosphoinositide_3-kinase_inhibitor"
            },
            {
                "resource": "ChEMBL",
                "identifier": "CHEMBL2396661"
            },
            {
                "resource": "ZINC",
                "identifier": "ZINC000068198368"
            },
            {
                "resource": "RxCUI",
                "identifier": "2169285"
            }
        ]
    },
    "external-links": null,
    "pathways": null,
    "reactions": {
        "reaction": {
            "sequence": "1",
            "left-element": {
                "drugbank-id": "DB12015",
                "name": "Alpelisib"
            },
            "right-element": {
                "drugbank-id": "DBMET02571",
                "name": "Alpelisib M4 Metabolite"
            },
            "enzymes": null
        }
    },
    "snp-effects": null,
    "snp-adverse-drug-reactions": null,
    "targets": {
        "target": {
            "@position": "1",
            "id": "BE0002379",
            "name": "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",
            "organism": "Humans",
            "actions": {
                "action": "inhibitor"
            },
            "references": {
                "articles": {
                    "article": [
                        {
                            "ref-id": "A179206",
                            "pubmed-id": "28852212",
                            "citation": "Chen IC, Hsiao LP, Huang IW, Yu HC, Yeh LC, Lin CH, Wei-Wu Chen T, Cheng AL, Lu YS: Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen. Sci Rep. 2017 Aug 29;7(1):9842. doi: 10.1038/s41598-017-10555-z."
                        },
                        {
                            "ref-id": "A179209",
                            "pubmed-id": "29109464",
                            "citation": "Yang X, Zhang X, Huang M, Song K, Li X, Huang M, Meng L, Zhang J: New Insights into PI3K Inhibitor Design using X-ray Structures of PI3Kalpha Complexed with a Potent Lead Compound. Sci Rep. 2017 Nov 6;7(1):14572. doi: 10.1038/s41598-017-15260-5."
                        }
                    ]
                },
                "textbooks": null,
                "links": null,
                "attachments": null
            },
            "known-action": "yes",
            "polypeptide": {
                "@id": "P42336",
                "@source": "Swiss-Prot",
                "name": "Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",
                "general-function": "Protein serine/threonine kinase activity",
                "specific-function": "Phosphoinositide-3-kinase (PI3K) that phosphorylates PtdIns (Phosphatidylinositol), PtdIns4P (Phosphatidylinositol 4-phosphate) and PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Participates in cellular signaling in response to various growth factors. Involved in the activation of AKT1 upon stimulation by receptor tyrosine kinases ligands such as EGF, insulin, IGF1, VEGFA and PDGF. Involved in signaling via insulin-receptor substrate (IRS) proteins. Essential in endothelial cell migration during vascular development through VEGFA signaling, possibly by regulating RhoA activity. Required for lymphatic vasculature development, possibly by binding to RAS and by activation by EGF and FGF2, but not by PDGF. Regulates invadopodia formation in breast cancer cells through the PDPK1-AKT1 pathway. Participates in cardiomyogenesis in embryonic stem cells through a AKT1 pathway. Participates in vasculogenesis in embryonic stem cells through PDK1 and protein kinase C pathway. Has also serine-protein kinase activity: phosphorylates PIK3R1 (p85alpha regulatory subunit), EIF4EBP1 and HRAS.",
                "gene-name": "PIK3CA",
                "locus": "3q26.3",
                "cellular-location": null,
                "transmembrane-regions": null,
                "signal-regions": null,
                "theoretical-pi": "7.23",
                "molecular-weight": "124283.025",
                "chromosome-location": "3",
                "organism": {
                    "@ncbi-taxonomy-id": "9606",
                    "#text": "Humans"
                },
                "external-identifiers": {
                    "external-identifier": [
                        {
                            "resource": "HUGO Gene Nomenclature Committee (HGNC)",
                            "identifier": "HGNC:8975"
                        },
                        {
                            "resource": "GenAtlas",
                            "identifier": "PIK3CA"
                        },
                        {
                            "resource": "GenBank Gene Database",
                            "identifier": "Z29090"
                        },
                        {
                            "resource": "Guide to Pharmacology",
                            "identifier": "2153"
                        },
                        {
                            "resource": "UniProtKB",
                            "identifier": "P42336"
                        },
                        {
                            "resource": "UniProt Accession",
                            "identifier": "PK3CA_HUMAN"
                        }
                    ]
                },
                "synonyms": {
                    "synonym": [
                        "2.7.1.153",
                        "p110alpha",
                        "Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha",
                        "Phosphoinositide-3-kinase catalytic alpha polypeptide",
                        "PI3-kinase subunit alpha",
                        "PtdIns-3-kinase subunit p110-alpha",
                        "Serine/threonine protein kinase PIK3CA"
                    ]
                },
                "amino-acid-sequence": {
                    "@format": "FASTA",
                    "#text": ">lcl|BSEQ0011705|Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform\nMPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQ\nLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFA\nIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKH\nIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLK\nLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMD\nCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGI\nYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHC\nPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWF\nSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPL\nSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAME\nLLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTN\nQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILK\nQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLW\nLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLS\nIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRS\nCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDF\nLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIA\nYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN"
                },
                "gene-sequence": {
                    "@format": "FASTA",
                    "#text": ">lcl|BSEQ0011706|Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PIK3CA)\nATGCCTCCACGACCATCATCAGGTGAACTGTGGGGCATCCACTTGATGCCCCCAAGAATC\nCTAGTAGAATGTTTACTACCAAATGGAATGATAGTGACTTTAGAATGCCTCCGTGAGGCT\nACATTAATAACCATAAAGCATGAACTATTTAAAGAAGCAAGAAAATACCCCCTCCATCAA\nCTTCTTCAAGATGAATCTTCTTACATTTTCGTAAGTGTTACTCAAGAAGCAGAAAGGGAA\nGAATTTTTTGATGAAACAAGACGACTTTGTGACCTTCGGCTTTTTCAACCCTTTTTAAAA\nGTAATTGAACCAGTAGGCAACCGTGAAGAAAAGATCCTCAATCGAGAAATTGGTTTTGCT\nATCGGCATGCCAGTGTGTGAATTTGATATGGTTAAAGATCCAGAAGTACAGGACTTCCGA\nAGAAATATTCTGAACGTTTGTAAAGAAGCTGTGGATCTTAGGGACCTCAATTCACCTCAT\nAGTAGAGCAATGTATGTCTATCCTCCAAATGTAGAATCTTCACCAGAATTGCCAAAGCAC\nATATATAATAAATTAGATAAAGGGCAAATAATAGTGGTGATCTGGGTAATAGTTTCTCCA\nAATAATGACAAGCAGAAGTATACTCTGAAAATCAACCATGACTGTGTACCAGAACAAGTA\nATTGCTGAAGCAATCAGGAAAAAAACTCGAAGTATGTTGCTATCCTCTGAACAACTAAAA\nCTCTGTGTTTTAGAATATCAGGGCAAGTATATTTTAAAAGTGTGTGGATGTGATGAATAC\nTTCCTAGAAAAATATCCTCTGAGTCAGTATAAGTATATAAGAAGCTGTATAATGCTTGGG\nAGGATGCCCAATTTGATGTTGATGGCTAAAGAAAGCCTTTATTCTCAACTGCCAATGGAC\nTGTTTTACAATGCCATCTTATTCCAGACGCATTTCCACAGCTACACCATATATGAATGGA\nGAAACATCTACAAAATCCCTTTGGGTTATAAATAGTGCACTCAGAATAAAAATTCTTTGT\nGCAACCTACGTGAATGTAAATATTCGAGACATTGATAAGATCTATGTTCGAACAGGTATC\nTACCATGGAGGAGAACCCTTATGTGACAATGTGAACACTCAAAGAGTACCTTGTTCCAAT\nCCCAGGTGGAATGAATGGCTGAATTATGATATATACATTCCTGATCTTCCTCGTGCTGCT\nCGACTTTGCCTTTCCATTTGCTCTGTTAAAGGCCGAAAGGGTGCTAAAGAGGAACACTGT\nCCATTGGCATGGGGAAATATAAACTTGTTTGATTACACAGACACTCTAGTATCTGGAAAA\nATGGCTTTGAATCTTTGGCCAGTACCTCATGGATTAGAAGATTTGCTGAACCCTATTGGT\nGTTACTGGATCAAATCCAAATAAAGAAACTCCATGCTTAGAGTTGGAGTTTGACTGGTTC\nAGCAGTGTGGTAAAGTTCCCAGATATGTCAGTGATTGAAGAGCATGCCAATTGGTCTGTA\nTCCCGAGAAGCAGGATTTAGCTATTCCCACGCAGGACTGAGTAACAGACTAGCTAGAGAC\nAATGAATTAAGGGAAAATGACAAAGAACAGCTCAAAGCAATTTCTACACGAGATCCTCTC\nTCTGAAATCACTGAGCAGGAGAAAGATTTTCTATGGAGTCACAGACACTATTGTGTAACT\nATCCCCGAAATTCTACCCAAATTGCTTCTGTCTGTTAAATGGAATTCTAGAGATGAAGTA\nGCCCAGATGTATTGCTTGGTAAAAGATTGGCCTCCAATCAAACCTGAACAGGCTATGGAA\nCTTCTGGACTGTAATTACCCAGATCCTATGGTTCGAGGTTTTGCTGTTCGGTGCTTGGAA\nAAATATTTAACAGATGACAAACTTTCTCAGTATTTAATTCAGCTAGTACAGGTCCTAAAA\nTATGAACAATATTTGGATAACTTGCTTGTGAGATTTTTACTGAAGAAAGCATTGACTAAT\nCAAAGGATTGGGCACTTTTTCTTTTGGCATTTAAAATCTGAGATGCACAATAAAACAGTT\nAGCCAGAGGTTTGGCCTGCTTTTGGAGTCCTATTGTCGTGCATGTGGGATGTATTTGAAG\nCACCTGAATAGGCAAGTCGAGGCAATGGAAAAGCTCATTAACTTAACTGACATTCTCAAA\nCAGGAGAAGAAGGATGAAACACAAAAGGTACAGATGAAGTTTTTAGTTGAGCAAATGAGG\nCGACCAGATTTCATGGATGCTCTACAGGGCTTTCTGTCTCCTCTAAACCCTGCTCATCAA\nCTAGGAAACCTCAGGCTTGAAGAGTGTCGAATTATGTCCTCTGCAAAAAGGCCACTGTGG\nTTGAATTGGGAGAACCCAGACATCATGTCAGAGTTACTGTTTCAGAACAATGAGATCATC\nTTTAAAAATGGGGATGATTTACGGCAAGATATGCTAACACTTCAAATTATTCGTATTATG\nGAAAATATCTGGCAAAATCAAGGTCTTGATCTTCGAATGTTACCTTATGGTTGTCTGTCA\nATCGGTGACTGTGTGGGACTTATTGAGGTGGTGCGAAATTCTCACACTATTATGCAAATT\nCAGTGCAAAGGCGGCTTGAAAGGTGCACTGCAGTTCAACAGCCACACACTACATCAGTGG\nCTCAAAGACAAGAACAAAGGAGAAATATATGATGCAGCCATTGACCTGTTTACACGTTCA\nTGTGCTGGATACTGTGTAGCTACCTTCATTTTGGGAATTGGAGATCGTCACAATAGTAAC\nATCATGGTGAAAGACGATGGACAACTGTTTCATATAGATTTTGGACACTTTTTGGATCAC\nAAGAAGAAAAAATTTGGTTATAAACGAGAACGTGTGCCATTTGTTTTGACACAGGATTTC\nTTAATAGTGATTAGTAAAGGAGCCCAAGAATGCACAAAGACAAGAGAATTTGAGAGGTTT\nCAGGAGATGTGTTACAAGGCTTATCTAGCTATTCGACAGCATGCCAATCTCTTCATAAAT\nCTTTTCTCAATGATGCTTGGCTCTGGAATGCCAGAACTACAATCTTTTGATGACATTGCA\nTACATTCGAAAGACCCTAGCCTTAGATAAAACTGAGCAAGAGGCTTTGGAGTATTTCATG\nAAACAAATGAATGATGCACATCATGGTGGCTGGACAACAAAAATGGATTGGATCTTCCAC\nACAATTAAACAGCATGCATTGAACTGA"
                },
                "pfams": {
                    "pfam": [
                        {
                            "identifier": "PF00454",
                            "name": "PI3_PI4_kinase"
                        },
                        {
                            "identifier": "PF00792",
                            "name": "PI3K_C2"
                        },
                        {
                            "identifier": "PF00794",
                            "name": "PI3K_rbd"
                        },
                        {
                            "identifier": "PF00613",
                            "name": "PI3Ka"
                        },
                        {
                            "identifier": "PF02192",
                            "name": "PI3K_p85B"
                        }
                    ]
                },
                "go-classifiers": {
                    "go-classifier": [
                        {
                            "category": "component",
                            "description": "cytosol"
                        },
                        {
                            "category": "component",
                            "description": "lamellipodium"
                        },
                        {
                            "category": "component",
                            "description": "phosphatidylinositol 3-kinase complex"
                        },
                        {
                            "category": "component",
                            "description": "phosphatidylinositol 3-kinase complex, class IA"
                        },
                        {
                            "category": "component",
                            "description": "plasma membrane"
                        },
                        {
                            "category": "function",
                            "description": "1-phosphatidylinositol-3-kinase activity"
                        },
                        {
                            "category": "function",
                            "description": "1-phosphatidylinositol-4-phosphate 3-kinase activity"
                        },
                        {
                            "category": "function",
                            "description": "ATP binding"
                        },
                        {
                            "category": "function",
                            "description": "kinase activity"
                        },
                        {
                            "category": "function",
                            "description": "phosphatidylinositol 3-kinase activity"
                        },
                        {
                            "category": "function",
                            "description": "phosphatidylinositol-4,5-bisphosphate 3-kinase activity"
                        },
                        {
                            "category": "function",
                            "description": "protein kinase activator activity"
                        },
                        {
                            "category": "function",
                            "description": "protein serine/threonine kinase activity"
                        },
                        {
                            "category": "process",
                            "description": "adipose tissue development"
                        },
                        {
                            "category": "process",
                            "description": "angiogenesis"
                        },
                        {
                            "category": "process",
                            "description": "blood coagulation"
                        },
                        {
                            "category": "process",
                            "description": "cardiac muscle contraction"
                        },
                        {
                            "category": "process",
                            "description": "cellular response to glucose stimulus"
                        },
                        {
                            "category": "process",
                            "description": "endothelial cell migration"
                        },
                        {
                            "category": "process",
                            "description": "energy homeostasis"
                        },
                        {
                            "category": "process",
                            "description": "epidermal growth factor receptor signaling pathway"
                        },
                        {
                            "category": "process",
                            "description": "Fc-epsilon receptor signaling pathway"
                        },
                        {
                            "category": "process",
                            "description": "Fc-gamma receptor signaling pathway involved in phagocytosis"
                        },
                        {
                            "category": "process",
                            "description": "fibroblast growth factor receptor signaling pathway"
                        },
                        {
                            "category": "process",
                            "description": "glucose metabolic process"
                        },
                        {
                            "category": "process",
                            "description": "hypomethylation of CpG island"
                        },
                        {
                            "category": "process",
                            "description": "innate immune response"
                        },
                        {
                            "category": "process",
                            "description": "insulin receptor signaling pathway"
                        },
                        {
                            "category": "process",
                            "description": "insulin receptor signaling pathway via phosphatidylinositol 3-kinase"
                        },
                        {
                            "category": "process",
                            "description": "leukocyte migration"
                        },
                        {
                            "category": "process",
                            "description": "liver development"
                        },
                        {
                            "category": "process",
                            "description": "mitophagy in response to mitochondrial depolarization"
                        },
                        {
                            "category": "process",
                            "description": "negative regulation of anoikis"
                        },
                        {
                            "category": "process",
                            "description": "negative regulation of fibroblast apoptotic process"
                        },
                        {
                            "category": "process",
                            "description": "negative regulation of neuron apoptotic process"
                        },
                        {
                            "category": "process",
                            "description": "neurotrophin TRK receptor signaling pathway"
                        },
                        {
                            "category": "process",
                            "description": "phosphatidylinositol biosynthetic process"
                        },
                        {
                            "category": "process",
                            "description": "phosphatidylinositol phosphorylation"
                        },
                        {
                            "category": "process",
                            "description": "phosphatidylinositol-3-phosphate biosynthetic process"
                        },
                        {
                            "category": "process",
                            "description": "phosphatidylinositol-mediated signaling"
                        },
                        {
                            "category": "process",
                            "description": "phospholipid metabolic process"
                        },
                        {
                            "category": "process",
                            "description": "platelet activation"
                        },
                        {
                            "category": "process",
                            "description": "positive regulation of peptidyl-serine phosphorylation"
                        },
                        {
                            "category": "process",
                            "description": "protein kinase B signaling"
                        },
                        {
                            "category": "process",
                            "description": "regulation of cellular respiration"
                        },
                        {
                            "category": "process",
                            "description": "regulation of genetic imprinting"
                        },
                        {
                            "category": "process",
                            "description": "regulation of multicellular organism growth"
                        },
                        {
                            "category": "process",
                            "description": "small molecule metabolic process"
                        },
                        {
                            "category": "process",
                            "description": "T cell costimulation"
                        },
                        {
                            "category": "process",
                            "description": "T cell receptor signaling pathway"
                        },
                        {
                            "category": "process",
                            "description": "vascular endothelial growth factor receptor signaling pathway"
                        },
                        {
                            "category": "process",
                            "description": "vasculature development"
                        }
                    ]
                }
            }
        }
    },
    "enzymes": {
        "enzyme": [
            {
                "@position": "1",
                "id": "BE0002638",
                "name": "Cytochrome P450 3A4",
                "organism": "Humans",
                "actions": {
                    "action": "substrate"
                },
                "references": {
                    "articles": {
                        "article": [
                            {
                                "ref-id": "A179257",
                                "pubmed-id": "28566285",
                                "citation": "James AD, Marvalin C, Luneau A, Meissner A, Camenisch G: Comparison of (19)F NMR and (14)C Measurements for the Assessment of ADME of BYL719 (Alpelisib) in Humans. Drug Metab Dispos. 2017 Aug;45(8):900-907. doi: 10.1124/dmd.117.075424. Epub 2017 May 31."
                            },
                            {
                                "ref-id": "A179254",
                                "pubmed-id": "26254025",
                                "citation": "James A, Blumenstein L, Glaenzel U, Jin Y, Demailly A, Jakab A, Hansen R, Hazell K, Mehta A, Trandafir L, Swart P: Absorption, distribution, metabolism, and excretion of [(14)C]BYL719 (alpelisib) in healthy male volunteers. Cancer Chemother Pharmacol. 2015 Oct;76(4):751-60. doi: 10.1007/s00280-015-2842-4. Epub 2015 Aug 8."
                            }
                        ]
                    },
                    "textbooks": null,
                    "links": {
                        "link": {
                            "ref-id": "L6655",
                            "title": "New Mexico Cancer Alliance: Compassionate Use of Alpelisib",
                            "url": "https://clinicaltrials.gov/ProvidedDocs/82/NCT03941782/Prot_000.pdf"
                        }
                    },
                    "attachments": null
                },
                "known-action": "unknown",
                "polypeptide": {
                    "@id": "P08684",
                    "@source": "Swiss-Prot",
                    "name": "Cytochrome P450 3A4",
                    "general-function": "Vitamin d3 25-hydroxylase activity",
                    "specific-function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).",
                    "gene-name": "CYP3A4",
                    "locus": "7q21.1",
                    "cellular-location": "Endoplasmic reticulum membrane",
                    "transmembrane-regions": "2-22",
                    "signal-regions": null,
                    "theoretical-pi": "8.25",
                    "molecular-weight": "57342.67",
                    "chromosome-location": "7",
                    "organism": {
                        "@ncbi-taxonomy-id": "9606",
                        "#text": "Humans"
                    },
                    "external-identifiers": {
                        "external-identifier": [
                            {
                                "resource": "HUGO Gene Nomenclature Committee (HGNC)",
                                "identifier": "HGNC:2637"
                            },
                            {
                                "resource": "GenAtlas",
                                "identifier": "CYP3A4"
                            },
                            {
                                "resource": "GenBank Gene Database",
                                "identifier": "M18907"
                            },
                            {
                                "resource": "Guide to Pharmacology",
                                "identifier": "1337"
                            },
                            {
                                "resource": "UniProtKB",
                                "identifier": "P08684"
                            },
                            {
                                "resource": "UniProt Accession",
                                "identifier": "CP3A4_HUMAN"
                            }
                        ]
                    },
                    "synonyms": {
                        "synonym": [
                            "1,8-cineole 2-exo-monooxygenase",
                            "1.14.13.-",
                            "Albendazole monooxygenase",
                            "Albendazole sulfoxidase",
                            "Cholesterol 25-hydroxylase",
                            "CYP3A3",
                            "CYPIIIA3",
                            "CYPIIIA4",
                            "Cytochrome P450 3A3",
                            "Cytochrome P450 HLp",
                            "Cytochrome P450 NF-25",
                            "Cytochrome P450-PCN1",
                            "Nifedipine oxidase",
                            "Quinine 3-monooxygenase",
                            "Taurochenodeoxycholate 6-alpha-hydroxylase"
                        ]
                    },
                    "amino-acid-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0021936|Cytochrome P450 3A4\nMALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF\nDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI\nAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS\nMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV\nFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI\nIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV\nNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS\nKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG\nGLLQPEKPVVLKVESRDGTVSGA"
                    },
                    "gene-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4)\nATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG\nCTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG\nCCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT\nGACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT\nGTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT\nGTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA\nGCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA\nAAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG\nAGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC\nATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA\nGACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT\nCTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT\nCCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC\nGAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA\nAAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC\nTTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG\nGCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT\nAAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT\nGAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT\nGAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT\nCACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG\nAAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC\nTGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG\nAACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA\nCTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT\nGGAGCCTGA"
                    },
                    "pfams": {
                        "pfam": {
                            "identifier": "PF00067",
                            "name": "p450"
                        }
                    },
                    "go-classifiers": {
                        "go-classifier": [
                            {
                                "category": "component",
                                "description": "cytoplasm"
                            },
                            {
                                "category": "component",
                                "description": "endoplasmic reticulum membrane"
                            },
                            {
                                "category": "component",
                                "description": "integral component of membrane"
                            },
                            {
                                "category": "component",
                                "description": "intracellular membrane-bounded organelle"
                            },
                            {
                                "category": "function",
                                "description": "albendazole monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "aromatase activity"
                            },
                            {
                                "category": "function",
                                "description": "caffeine oxidase activity"
                            },
                            {
                                "category": "function",
                                "description": "enzyme binding"
                            },
                            {
                                "category": "function",
                                "description": "heme binding"
                            },
                            {
                                "category": "function",
                                "description": "iron ion binding"
                            },
                            {
                                "category": "function",
                                "description": "monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "oxidoreductase activity"
                            },
                            {
                                "category": "function",
                                "description": "oxygen binding"
                            },
                            {
                                "category": "function",
                                "description": "quinine 3-monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "steroid binding"
                            },
                            {
                                "category": "function",
                                "description": "steroid hydroxylase activity"
                            },
                            {
                                "category": "function",
                                "description": "taurochenodeoxycholate 6alpha-hydroxylase activity"
                            },
                            {
                                "category": "function",
                                "description": "testosterone 6-beta-hydroxylase activity"
                            },
                            {
                                "category": "function",
                                "description": "vitamin D 24-hydroxylase activity"
                            },
                            {
                                "category": "function",
                                "description": "vitamin D3 25-hydroxylase activity"
                            },
                            {
                                "category": "process",
                                "description": "alkaloid catabolic process"
                            },
                            {
                                "category": "process",
                                "description": "androgen metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "calcitriol biosynthetic process from calciol"
                            },
                            {
                                "category": "process",
                                "description": "drug catabolic process"
                            },
                            {
                                "category": "process",
                                "description": "drug metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "exogenous drug catabolic process"
                            },
                            {
                                "category": "process",
                                "description": "heterocycle metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "lipid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "monoterpenoid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "oxidation-reduction process"
                            },
                            {
                                "category": "process",
                                "description": "oxidative demethylation"
                            },
                            {
                                "category": "process",
                                "description": "small molecule metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "steroid catabolic process"
                            },
                            {
                                "category": "process",
                                "description": "steroid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "vitamin D metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "xenobiotic metabolic process"
                            }
                        ]
                    }
                },
                "inhibition-strength": null,
                "induction-strength": null
            },
            {
                "@position": "2",
                "id": "BE0002793",
                "name": "Cytochrome P450 2C9",
                "organism": "Humans",
                "actions": {
                    "action": "inducer"
                },
                "references": {
                    "articles": {
                        "article": {
                            "ref-id": "A179263",
                            "pubmed-id": "28537878",
                            "citation": "Rewcastle GW, Kolekar S, Buchanan CM, Gamage SA, Giddens AC, Tsang KY, Kendall JD, Singh R, Lee WJ, Smith GC, Han W, Matthews DJ, Denny WA, Shepherd PR, Jamieson SMF: Biological characterization of SN32976, a selective inhibitor of PI3K and mTOR with preferential activity to PI3Kalpha, in comparison to established pan PI3K inhibitors. Oncotarget. 2017 Jul 18;8(29):47725-47740. doi: 10.18632/oncotarget.17730."
                        }
                    },
                    "textbooks": null,
                    "links": {
                        "link": {
                            "ref-id": "L6655",
                            "title": "New Mexico Cancer Alliance: Compassionate Use of Alpelisib",
                            "url": "https://clinicaltrials.gov/ProvidedDocs/82/NCT03941782/Prot_000.pdf"
                        }
                    },
                    "attachments": null
                },
                "known-action": "unknown",
                "polypeptide": {
                    "@id": "P11712",
                    "@source": "Swiss-Prot",
                    "name": "Cytochrome P450 2C9",
                    "general-function": "Steroid hydroxylase activity",
                    "specific-function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.",
                    "gene-name": "CYP2C9",
                    "locus": "10q24",
                    "cellular-location": "Endoplasmic reticulum membrane",
                    "transmembrane-regions": null,
                    "signal-regions": null,
                    "theoretical-pi": "7.99",
                    "molecular-weight": "55627.365",
                    "chromosome-location": "10",
                    "organism": {
                        "@ncbi-taxonomy-id": "9606",
                        "#text": "Humans"
                    },
                    "external-identifiers": {
                        "external-identifier": [
                            {
                                "resource": "HUGO Gene Nomenclature Committee (HGNC)",
                                "identifier": "HGNC:2623"
                            },
                            {
                                "resource": "GenAtlas",
                                "identifier": "CYP2C9"
                            },
                            {
                                "resource": "GenBank Gene Database",
                                "identifier": "AY341248"
                            },
                            {
                                "resource": "Guide to Pharmacology",
                                "identifier": "1326"
                            },
                            {
                                "resource": "UniProtKB",
                                "identifier": "P11712"
                            },
                            {
                                "resource": "UniProt Accession",
                                "identifier": "CP2C9_HUMAN"
                            }
                        ]
                    },
                    "synonyms": {
                        "synonym": [
                            "(R)-limonene 6-monooxygenase",
                            "(S)-limonene 6-monooxygenase",
                            "(S)-limonene 7-monooxygenase",
                            "1.14.13.-",
                            "Cholesterol 25-hydroxylase",
                            "CYP2C10",
                            "CYPIIC9",
                            "Cytochrome P-450MP",
                            "Cytochrome P450 MP-4",
                            "Cytochrome P450 MP-8",
                            "Cytochrome P450 PB-1",
                            "S-mephenytoin 4-hydroxylase"
                        ]
                    },
                    "amino-acid-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0005471|Cytochrome P450 2C9\nMDSLVVLVLCLSCLLLLSLWRQSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKV\nYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFM\nKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYID\nLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFK\nKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVP\nPFYQLCFIPV"
                    },
                    "gene-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0016893|Cytochrome P450 2C9 (CYP2C9)\nATGGATTCTCTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCACTCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGGTATTAAGGACATCAGCAAATCCTTAACCAATCTCTCAAAGGTC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGAAACCCATAGTGGTGCTGCATGGATAT\nGAAGCAGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCATTTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATTGTTTTCAGCAATGGAAAGAAATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCCTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCATAAACGTTTTGATTATAAAGATCAGCAATTTCTTAACTTAATGGAAAAG\nTTGAATGAAAACATCAAGATTTTGAGCAGCCCCTGGATCCAGATCTGCAATAATTTTTCT\nCCTATCATTGATTACTTCCCGGGAACTCACAACAAATTACTTAAAAACGTTGCTTTTATG\nAAAAGTTATATTTTGGAAAAAGTAAAAGAACACCAAGAATCAATGGACATGAACAACCCT\nCAGGACTTTATTGATTGCTTCCTGATGAAAATGGAGAAGGAAAAGCACAACCAACCATCT\nGAATTTACTATTGAAAGCTTGGAAAACACTGCAGTTGACTTGTTTGGAGCTGGGACAGAG\nACGACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTGATTGGCAGAAACCGGAGCCCCTGCATGCAA\nGACAGGAGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATTGAC\nCTTCTCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACATTAAATTCAGAAACTATCTC\nATTCCCAAGGGCACAACCATATTAATTTCCCTGACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCATCACTTTCTGGATGAAGGTGGCAATTTTAAG\nAAAAGTAAATACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAAGCCCTG\nGCCGGCATGGAGCTGTTTTTATTCCTGACCTCCATTTTACAGAACTTTAACCTGAAATCT\nCTGGTTGACCCAAAGAACCTTGACACCACTCCAGTTGTCAATGGATTTGCCTCTGTGCCG\nCCCTTCTACCAGCTGTGCTTCATTCCTGTCTGA"
                    },
                    "pfams": {
                        "pfam": {
                            "identifier": "PF00067",
                            "name": "p450"
                        }
                    },
                    "go-classifiers": {
                        "go-classifier": [
                            {
                                "category": "component",
                                "description": "cytoplasm"
                            },
                            {
                                "category": "component",
                                "description": "endoplasmic reticulum membrane"
                            },
                            {
                                "category": "component",
                                "description": "intracellular membrane-bounded organelle"
                            },
                            {
                                "category": "function",
                                "description": "(R)-limonene 6-monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "(S)-limonene 6-monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "(S)-limonene 7-monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "arachidonic acid epoxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "aromatase activity"
                            },
                            {
                                "category": "function",
                                "description": "caffeine oxidase activity"
                            },
                            {
                                "category": "function",
                                "description": "drug binding"
                            },
                            {
                                "category": "function",
                                "description": "heme binding"
                            },
                            {
                                "category": "function",
                                "description": "iron ion binding"
                            },
                            {
                                "category": "function",
                                "description": "monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "oxidoreductase activity"
                            },
                            {
                                "category": "function",
                                "description": "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"
                            },
                            {
                                "category": "function",
                                "description": "oxygen binding"
                            },
                            {
                                "category": "function",
                                "description": "steroid hydroxylase activity"
                            },
                            {
                                "category": "process",
                                "description": "arachidonic acid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "cellular amide metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "drug catabolic process"
                            },
                            {
                                "category": "process",
                                "description": "drug metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "epoxygenase P450 pathway"
                            },
                            {
                                "category": "process",
                                "description": "exogenous drug catabolic process"
                            },
                            {
                                "category": "process",
                                "description": "monocarboxylic acid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "monoterpenoid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "omega-hydroxylase P450 pathway"
                            },
                            {
                                "category": "process",
                                "description": "oxidation-reduction process"
                            },
                            {
                                "category": "process",
                                "description": "oxidative demethylation"
                            },
                            {
                                "category": "process",
                                "description": "small molecule metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "steroid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "urea metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "xenobiotic metabolic process"
                            }
                        ]
                    }
                },
                "inhibition-strength": null,
                "induction-strength": "unknown"
            },
            {
                "@position": "3",
                "id": "BE0002887",
                "name": "Cytochrome P450 2C8",
                "organism": "Humans",
                "actions": {
                    "action": "inhibitor"
                },
                "references": {
                    "articles": null,
                    "textbooks": null,
                    "links": {
                        "link": {
                            "ref-id": "L6655",
                            "title": "New Mexico Cancer Alliance: Compassionate Use of Alpelisib",
                            "url": "https://clinicaltrials.gov/ProvidedDocs/82/NCT03941782/Prot_000.pdf"
                        }
                    },
                    "attachments": null
                },
                "known-action": "unknown",
                "polypeptide": {
                    "@id": "P10632",
                    "@source": "Swiss-Prot",
                    "name": "Cytochrome P450 2C8",
                    "general-function": "Steroid hydroxylase activity",
                    "specific-function": "Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol).",
                    "gene-name": "CYP2C8",
                    "locus": "10q23.33",
                    "cellular-location": "Endoplasmic reticulum membrane",
                    "transmembrane-regions": null,
                    "signal-regions": null,
                    "theoretical-pi": "8.62",
                    "molecular-weight": "55824.275",
                    "chromosome-location": "10",
                    "organism": {
                        "@ncbi-taxonomy-id": "9606",
                        "#text": "Humans"
                    },
                    "external-identifiers": {
                        "external-identifier": [
                            {
                                "resource": "HUGO Gene Nomenclature Committee (HGNC)",
                                "identifier": "HGNC:2622"
                            },
                            {
                                "resource": "GenAtlas",
                                "identifier": "CYP2C8"
                            },
                            {
                                "resource": "GenBank Gene Database",
                                "identifier": "M17397"
                            },
                            {
                                "resource": "Guide to Pharmacology",
                                "identifier": "1325"
                            },
                            {
                                "resource": "UniProtKB",
                                "identifier": "P10632"
                            },
                            {
                                "resource": "UniProt Accession",
                                "identifier": "CP2C8_HUMAN"
                            }
                        ]
                    },
                    "synonyms": {
                        "synonym": [
                            "1.14.14.1",
                            "CYPIIC8",
                            "Cytochrome P450 form 1",
                            "Cytochrome P450 IIC2",
                            "Cytochrome P450 MP-12",
                            "Cytochrome P450 MP-20",
                            "S-mephenytoin 4-hydroxylase"
                        ]
                    },
                    "amino-acid-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0005650|Cytochrome P450 2C8\nMEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKV\nYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRW\nKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICS\nVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALT\nRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTE\nTTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSD\nLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFK\nKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLP\nPSYQICFIPV"
                    },
                    "gene-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0021338|Cytochrome P450 2C8 (CYP2C8)\nATGGAACCTTTTGTGGTCCTGGTGCTGTGTCTCTCTTTTATGCTTCTCTTTTCACTCTGG\nAGACAGAGCTGTAGGAGAAGGAAGCTCCCTCCTGGCCCCACTCCTCTTCCTATTATTGGA\nAATATGCTACAGATAGATGTTAAGGACATCTGCAAATCTTTCACCAATTTCTCAAAAGTC\nTATGGTCCTGTGTTCACCGTGTATTTTGGCATGAATCCCATAGTGGTGTTTCATGGATAT\nGAGGCAGTGAAGGAAGCCCTGATTGATAATGGAGAGGAGTTTTCTGGAAGAGGCAATTCC\nCCAATATCTCAAAGAATTACTAAAGGACTTGGAATCATTTCCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCACAACCTTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCTCACTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nGTTGTTTTCCAGAAACGATTTGATTATAAAGATCAGAATTTTCTCACCCTGATGAAAAGA\nTTCAATGAAAACTTCAGGATTCTGAACTCCCCATGGATCCAGGTCTGCAATAATTTCCCT\nCTACTCATTGATTGTTTCCCAGGAACTCACAACAAAGTGCTTAAAAATGTTGCTCTTACA\nCGAAGTTACATTAGGGAGAAAGTAAAAGAACACCAAGCATCACTGGATGTTAACAATCCT\nCGGGACTTTATCGATTGCTTCCTGATCAAAATGGAGCAGGAAAAGGACAACCAAAAGTCA\nGAATTCAATATTGAAAACTTGGTTGGCACTGTAGCTGATCTATTTGTTGCTGGAACAGAG\nACAACAAGCACCACTCTGAGATATGGACTCCTGCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGATCATGTAATTGGCAGACACAGGAGCCCCTGCATGCAG\nGATAGGAGCCACATGCCTTACACTGATGCTGTAGTGCACGAGATCCAGAGATACAGTGAC\nCTTGTCCCCACCGGTGTGCCCCATGCAGTGACCACTGATACTAAGTTCAGAAACTACCTC\nATCCCCAAGGGCACAACCATAATGGCATTACTGACTTCCGTGCTACATGATGACAAAGAA\nTTTCCTAATCCAAATATCTTTGACCCTGGCCACTTTCTAGATAAGAATGGCAACTTTAAG\nAAAAGTGACTACTTCATGCCTTTCTCAGCAGGAAAACGAATTTGTGCAGGAGAAGGACTT\nGCCCGCATGGAGCTATTTTTATTTCTAACCACAATTTTACAGAACTTTAACCTGAAATCT\nGTTGATGATTTAAAGAACCTCAATACTACTGCAGTTACCAAAGGGATTGTTTCTCTGCCA\nCCCTCATACCAGATCTGCTTCATCCCTGTCTGA"
                    },
                    "pfams": {
                        "pfam": {
                            "identifier": "PF00067",
                            "name": "p450"
                        }
                    },
                    "go-classifiers": {
                        "go-classifier": [
                            {
                                "category": "component",
                                "description": "cytoplasm"
                            },
                            {
                                "category": "component",
                                "description": "endoplasmic reticulum membrane"
                            },
                            {
                                "category": "component",
                                "description": "intracellular membrane-bounded organelle"
                            },
                            {
                                "category": "function",
                                "description": "arachidonic acid epoxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "aromatase activity"
                            },
                            {
                                "category": "function",
                                "description": "caffeine oxidase activity"
                            },
                            {
                                "category": "function",
                                "description": "heme binding"
                            },
                            {
                                "category": "function",
                                "description": "iron ion binding"
                            },
                            {
                                "category": "function",
                                "description": "monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"
                            },
                            {
                                "category": "function",
                                "description": "oxygen binding"
                            },
                            {
                                "category": "function",
                                "description": "steroid hydroxylase activity"
                            },
                            {
                                "category": "process",
                                "description": "arachidonic acid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "drug metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "epoxygenase P450 pathway"
                            },
                            {
                                "category": "process",
                                "description": "exogenous drug catabolic process"
                            },
                            {
                                "category": "process",
                                "description": "omega-hydroxylase P450 pathway"
                            },
                            {
                                "category": "process",
                                "description": "organic acid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "oxidation-reduction process"
                            },
                            {
                                "category": "process",
                                "description": "oxidative demethylation"
                            },
                            {
                                "category": "process",
                                "description": "small molecule metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "xenobiotic metabolic process"
                            }
                        ]
                    }
                },
                "inhibition-strength": "unknown",
                "induction-strength": null
            },
            {
                "@position": "4",
                "id": "BE0003536",
                "name": "Cytochrome P450 2C19",
                "organism": "Humans",
                "actions": {
                    "action": "inhibitor"
                },
                "references": {
                    "articles": null,
                    "textbooks": null,
                    "links": {
                        "link": {
                            "ref-id": "L6655",
                            "title": "New Mexico Cancer Alliance: Compassionate Use of Alpelisib",
                            "url": "https://clinicaltrials.gov/ProvidedDocs/82/NCT03941782/Prot_000.pdf"
                        }
                    },
                    "attachments": null
                },
                "known-action": "unknown",
                "polypeptide": {
                    "@id": "P33261",
                    "@source": "Swiss-Prot",
                    "name": "Cytochrome P450 2C19",
                    "general-function": "Steroid hydroxylase activity",
                    "specific-function": "Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine.",
                    "gene-name": "CYP2C19",
                    "locus": "10q24.1-q24.3",
                    "cellular-location": "Endoplasmic reticulum membrane",
                    "transmembrane-regions": null,
                    "signal-regions": null,
                    "theoretical-pi": "7.42",
                    "molecular-weight": "55930.545",
                    "chromosome-location": "10",
                    "organism": {
                        "@ncbi-taxonomy-id": "9606",
                        "#text": "Humans"
                    },
                    "external-identifiers": {
                        "external-identifier": [
                            {
                                "resource": "HUGO Gene Nomenclature Committee (HGNC)",
                                "identifier": "HGNC:2621"
                            },
                            {
                                "resource": "GenBank Gene Database",
                                "identifier": "M61854"
                            },
                            {
                                "resource": "GenBank Protein Database",
                                "identifier": "181344"
                            },
                            {
                                "resource": "Guide to Pharmacology",
                                "identifier": "1328"
                            },
                            {
                                "resource": "UniProtKB",
                                "identifier": "P33261"
                            },
                            {
                                "resource": "UniProt Accession",
                                "identifier": "CP2CJ_HUMAN"
                            }
                        ]
                    },
                    "synonyms": {
                        "synonym": [
                            "(R)-limonene 6-monooxygenase",
                            "(S)-limonene 6-monooxygenase",
                            "(S)-limonene 7-monooxygenase",
                            "1.14.13.-",
                            "CYPIIC17",
                            "CYPIIC19",
                            "Cytochrome P450-11A",
                            "Cytochrome P450-254C",
                            "Mephenytoin 4-hydroxylase"
                        ]
                    },
                    "amino-acid-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0020694|Cytochrome P450 2C19\nMDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDVSKSLTNLSKI\nYGPVFTLYFGLERMVVLHGYEVVKEALIDLGEEFSGRGHFPLAERANRGFGIVFSNGKRW\nKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICS\nIIFQKRFDYKDQQFLNLMEKLNENIRIVSTPWIQICNNFPTIIDYFPGTHNKLLKNLAFM\nESDILEKVKEHQESMDINNPRDFIDCFLIKMEKEKQNQQSEFTIENLVITAADLLGAGTE\nTTSTTLRYALLLLLKHPEVTAKVQEEIERVVGRNRSPCMQDRGHMPYTDAVVHEVQRYID\nLIPTSLPHAVTCDVKFRNYLIPKGTTILTSLTSVLHDNKEFPNPEMFDPRHFLDEGGNFK\nKSNYFMPFSAGKRICVGEGLARMELFLFLTFILQNFNLKSLIDPKDLDTTPVVNGFASVP\nPFYQLCFIPV"
                    },
                    "gene-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0020695|Cytochrome P450 2C19 (CYP2C19)\nATGGATCCTTTTGTGGTCCTTGTGCTCTGTCTCTCATGTTTGCTTCTCCTTTCAATCTGG\nAGACAGAGCTCTGGGAGAGGAAAACTCCCTCCTGGCCCCACTCCTCTCCCAGTGATTGGA\nAATATCCTACAGATAGATATTAAGGATGTCAGCAAATCCTTAACCAATCTCTCAAAAATC\nTATGGCCCTGTGTTCACTCTGTATTTTGGCCTGGAACGCATGGTGGTGCTGCATGGATAT\nGAAGTGGTGAAGGAAGCCCTGATTGATCTTGGAGAGGAGTTTTCTGGAAGAGGCCATTTC\nCCACTGGCTGAAAGAGCTAACAGAGGATTTGGAATCGTTTTCAGCAATGGAAAGAGATGG\nAAGGAGATCCGGCGTTTCTCCCTCATGACGCTGCGGAATTTTGGGATGGGGAAGAGGAGC\nATTGAGGACCGTGTTCAAGAGGAAGCCCGCTGCCTTGTGGAGGAGTTGAGAAAAACCAAG\nGCTTCACCCTGTGATCCCACTTTCATCCTGGGCTGTGCTCCCTGCAATGTGATCTGCTCC\nATTATTTTCCAGAAACGTTTCGATTATAAAGATCAGCAATTTCTTAACTTGATGGAAAAA\nTTGAATGAAAACATCAGGATTGTAAGCACCCCCTGGATCCAGATATGCAATAATTTTCCC\nACTATCATTGATTATTTCCCGGGAACCCATAACAAATTACTTAAAAACCTTGCTTTTATG\nGAAAGTGATATTTTGGAGAAAGTAAAAGAACACCAAGAATCGATGGACATCAACAACCCT\nCGGGACTTTATTGATTGCTTCCTGATCAAAATGGAGAAGGAAAAGCAAAACCAACAGTCT\nGAATTCACTATTGAAAACTTGGTAATCACTGCAGCTGACTTACTTGGAGCTGGGACAGAG\nACAACAAGCACAACCCTGAGATATGCTCTCCTTCTCCTGCTGAAGCACCCAGAGGTCACA\nGCTAAAGTCCAGGAAGAGATTGAACGTGTCATTGGCAGAAACCGGAGCCCCTGCATGCAG\nGACAGGGGCCACATGCCCTACACAGATGCTGTGGTGCACGAGGTCCAGAGATACATCGAC\nCTCATCCCCACCAGCCTGCCCCATGCAGTGACCTGTGACGTTAAATTCAGAAACTACCTC\nATTCCCAAGGGCACAACCATATTAACTTCCCTCACTTCTGTGCTACATGACAACAAAGAA\nTTTCCCAACCCAGAGATGTTTGACCCTCGTCACTTTCTGGATGAAGGTGGAAATTTTAAG\nAAAAGTAACTACTTCATGCCTTTCTCAGCAGGAAAACGGATTTGTGTGGGAGAGGGCCTG\nGCCCGCATGGAGCTGTTTTTATTCCTGACCTTCATTTTACAGAACTTTAACCTGAAATCT\nCTGATTGACCCAAAGGACCTTGACACAACTCCTGTTGTCAATGGATTTGCTTCTGTCCCG\nCCCTTCTATCAGCTGTGCTTCATTCCTGTCTGA"
                    },
                    "pfams": {
                        "pfam": {
                            "identifier": "PF00067",
                            "name": "p450"
                        }
                    },
                    "go-classifiers": {
                        "go-classifier": [
                            {
                                "category": "component",
                                "description": "cytoplasm"
                            },
                            {
                                "category": "component",
                                "description": "endoplasmic reticulum membrane"
                            },
                            {
                                "category": "component",
                                "description": "intracellular membrane-bounded organelle"
                            },
                            {
                                "category": "function",
                                "description": "(R)-limonene 6-monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "(S)-limonene 6-monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "(S)-limonene 7-monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "arachidonic acid epoxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "enzyme binding"
                            },
                            {
                                "category": "function",
                                "description": "heme binding"
                            },
                            {
                                "category": "function",
                                "description": "iron ion binding"
                            },
                            {
                                "category": "function",
                                "description": "monooxygenase activity"
                            },
                            {
                                "category": "function",
                                "description": "oxidoreductase activity"
                            },
                            {
                                "category": "function",
                                "description": "oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen"
                            },
                            {
                                "category": "function",
                                "description": "oxygen binding"
                            },
                            {
                                "category": "function",
                                "description": "steroid hydroxylase activity"
                            },
                            {
                                "category": "process",
                                "description": "arachidonic acid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "drug metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "epoxygenase P450 pathway"
                            },
                            {
                                "category": "process",
                                "description": "exogenous drug catabolic process"
                            },
                            {
                                "category": "process",
                                "description": "heterocycle metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "monoterpenoid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "omega-hydroxylase P450 pathway"
                            },
                            {
                                "category": "process",
                                "description": "oxidation-reduction process"
                            },
                            {
                                "category": "process",
                                "description": "small molecule metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "steroid metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "xenobiotic metabolic process"
                            }
                        ]
                    }
                },
                "inhibition-strength": "unknown",
                "induction-strength": null
            }
        ]
    },
    "carriers": null,
    "transporters": {
        "transporter": [
            {
                "@position": "1",
                "id": "BE0001067",
                "name": "ATP-binding cassette sub-family G member 2",
                "organism": "Humans",
                "actions": {
                    "action": "substrate"
                },
                "references": {
                    "articles": null,
                    "textbooks": null,
                    "links": {
                        "link": {
                            "ref-id": "L6655",
                            "title": "New Mexico Cancer Alliance: Compassionate Use of Alpelisib",
                            "url": "https://clinicaltrials.gov/ProvidedDocs/82/NCT03941782/Prot_000.pdf"
                        }
                    },
                    "attachments": null
                },
                "known-action": "unknown",
                "polypeptide": {
                    "@id": "Q9UNQ0",
                    "@source": "Swiss-Prot",
                    "name": "ATP-binding cassette sub-family G member 2",
                    "general-function": "Xenobiotic-transporting atpase activity",
                    "specific-function": "High-capacity urate exporter functioning in both renal and extrarenal urate excretion. Plays a role in porphyrin homeostasis as it is able to mediates the export of protoporhyrin IX (PPIX) both from mitochondria to cytosol and from cytosol to extracellular space, and cellular export of hemin, and heme. Xenobiotic transporter that may play an important role in the exclusion of xenobiotics from the brain. Appears to play a major role in the multidrug resistance phenotype of several cancer cell lines. Implicated in the efflux of numerous drugs and xenobiotics: mitoxantrone, the photosensitizer pheophorbide, camptothecin, methotrexate, azidothymidine (AZT), and the anthracyclines daunorubicin and doxorubicin.",
                    "gene-name": "ABCG2",
                    "locus": "4q22",
                    "cellular-location": "Cell membrane",
                    "transmembrane-regions": "396-416\n429-449\n478-498\n507-527\n536-556\n631-651",
                    "signal-regions": null,
                    "theoretical-pi": "8.9",
                    "molecular-weight": "72313.47",
                    "chromosome-location": "4",
                    "organism": {
                        "@ncbi-taxonomy-id": "9606",
                        "#text": "Humans"
                    },
                    "external-identifiers": {
                        "external-identifier": [
                            {
                                "resource": "HUGO Gene Nomenclature Committee (HGNC)",
                                "identifier": "HGNC:74"
                            },
                            {
                                "resource": "GenAtlas",
                                "identifier": "ABCG2"
                            },
                            {
                                "resource": "GenBank Gene Database",
                                "identifier": "AF103796"
                            },
                            {
                                "resource": "GenBank Protein Database",
                                "identifier": "4185796"
                            },
                            {
                                "resource": "Guide to Pharmacology",
                                "identifier": "792"
                            },
                            {
                                "resource": "UniProtKB",
                                "identifier": "Q9UNQ0"
                            },
                            {
                                "resource": "UniProt Accession",
                                "identifier": "ABCG2_HUMAN"
                            }
                        ]
                    },
                    "synonyms": {
                        "synonym": [
                            "ABCP",
                            "BCRP",
                            "BCRP1",
                            "Breast cancer resistance protein",
                            "CDw338",
                            "Mitoxantrone resistance-associated protein",
                            "MXR",
                            "Placenta-specific ATP-binding cassette transporter",
                            "Urate exporter"
                        ]
                    },
                    "amino-acid-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0002125|ATP-binding cassette sub-family G member 2\nMSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKSGFLPCRKPVE\nKEILSNINGIMKPGLNAILGPTGGGKSSLLDVLAARKDPSGLSGDVLINGAPRPANFKCN\nSGYVVQDDVVMGTLTVRENLQFSAALRLATTMTNHEKNERINRVIQELGLDKVADSKVGT\nQFIRGVSGGERKRTSIGMELITDPSILFLDEPTTGLDSSTANAVLLLLKRMSKQGRTIIF\nSIHQPRYSIFKLFDSLTLLASGRLMFHGPAQEALGYFESAGYHCEAYNNPADFFLDIING\nDSTAVALNREEDFKATEIIEPSKQDKPLIEKLAEIYVNSSFYKETKAELHQLSGGEKKKK\nITVFKEISYTTSFCHQLRWVSKRSFKNLLGNPQASIAQIIVTVVLGLVIGAIYFGLKNDS\nTGIQNRAGVLFFLTTNQCFSSVSAVELFVVEKKLFIHEYISGYYRVSSYFLGKLLSDLLP\nMRMLPSIIFTCIVYFMLGLKPKADAFFVMMFTLMMVAYSASSMALAIAAGQSVVSVATLL\nMTICFVFMMIFSGLLVNLTTIASWLSWLQYFSIPRYGFTALQHNEFLGQNFCPGLNATGN\nNPCNYATCTGEEYLVKQGIDLSPWGLWKNHVALACMIVIFLTIAYLKLLFLKKYS"
                    },
                    "gene-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0016303|ATP-binding cassette sub-family G member 2 (ABCG2)\nATGTCTTCCAGTAATGTCGAAGTTTTTATCCCAGTGTCACAAGGAAACACCAATGGCTTC\nCCCGCGACAGCTTCCAATGACCTGAAGGCATTTACTGAAGGAGCTGTGTTAAGTTTTCAT\nAACATCTGCTATCGAGTAAAACTGAAGAGTGGCTTTCTACCTTGTCGAAAACCAGTTGAG\nAAAGAAATATTATCGAATATCAATGGGATCATGAAACCTGGTCTCAACGCCATCCTGGGA\nCCCACAGGTGGAGGCAAATCTTCGTTATTAGATGTCTTAGCTGCAAGGAAAGATCCAAGT\nGGATTATCTGGAGATGTTCTGATAAATGGAGCACCGCGACCTGCCAATTTCAAATGTAAT\nTCAGGTTACGTGGTACAAGATGATGTTGTGATGGGCACTCTGACGGTGAGAGAAAACTTA\nCAGTTCTCAGCAGCTCTTCGGCTTGCAACAACTATGACGAATCATGAAAAAAACGAACGG\nATTAACAGGGTCATTCAAGAGTTAGGTCTGGATAAAGTGGCAGACTCCAAGGTTGGAACT\nCAGTTTATCCGTGGTGTGTCTGGAGGAGAAAGAAAAAGGACTAGTATAGGAATGGAGCTT\nATCACTGATCCTTCCATCTTGTTCTTGGATGAGCCTACAACTGGCTTAGACTCAAGCACA\nGCAAATGCTGTCCTTTTGCTCCTGAAAAGGATGTCTAAGCAGGGACGAACAATCATCTTC\nTCCATTCATCAGCCTCGATATTCCATCTTCAAGTTGTTTGATAGCCTCACCTTATTGGCC\nTCAGGAAGACTTATGTTCCACGGGCCTGCTCAGGAGGCCTTGGGATACTTTGAATCAGCT\nGGTTATCACTGTGAGGCCTATAATAACCCTGCAGACTTCTTCTTGGACATCATTAATGGA\nGATTCCACTGCTGTGGCATTAAACAGAGAAGAAGACTTTAAAGCCACAGAGATCATAGAG\nCCTTCCAAGCAGGATAAGCCACTCATAGAAAAATTAGCGGAGATTTATGTCAACTCCTCC\nTTCTACAAAGAGACAAAAGCTGAATTACATCAACTTTCCGGGGGTGAGAAGAAGAAGAAG\nATCACAGTCTTCAAGGAGATCAGCTACACCACCTCCTTCTGTCATCAACTCAGATGGGTT\nTCCAAGCGTTCATTCAAAAACTTGCTGGGTAATCCCCAGGCCTCTATAGCTCAGATCATT\nGTCACAGTCGTACTGGGACTGGTTATAGGTGCCATTTACTTTGGGCTAAAAAATGATTCT\nACTGGAATCCAGAACAGAGCTGGGGTTCTCTTCTTCCTGACGACCAACCAGTGTTTCAGC\nAGTGTTTCAGCCGTGGAACTCTTTGTGGTAGAGAAGAAGCTCTTCATACATGAATACATC\nAGCGGATACTACAGAGTGTCATCTTATTTCCTTGGAAAACTGTTATCTGATTTATTACCC\nATGAGGATGTTACCAAGTATTATATTTACCTGTATAGTGTACTTCATGTTAGGATTGAAG\nCCAAAGGCAGATGCCTTCTTCGTTATGATGTTTACCCTTATGATGGTGGCTTATTCAGCC\nAGTTCCATGGCACTGGCCATAGCAGCAGGTCAGAGTGTGGTTTCTGTAGCAACACTTCTC\nATGACCATCTGTTTTGTGTTTATGATGGTCTGTTGGTCAATCTCACAACCATTGCATCTT\nGGCTGTCATGGCTTCAGTACTTCAGCATTCCACGATATGGATTTACGGCTTTGCAGCATA\nATGAATTTTTGGGACAAAACTTCTGCCCAGGACTCAATGCAACAGGAAACAATCCTTGTA\nACTATGCAACATGTACTGGCGAAGAATATTTGGTAA"
                    },
                    "pfams": {
                        "pfam": [
                            {
                                "identifier": "PF00005",
                                "name": "ABC_tran"
                            },
                            {
                                "identifier": "PF01061",
                                "name": "ABC2_membrane"
                            }
                        ]
                    },
                    "go-classifiers": {
                        "go-classifier": [
                            {
                                "category": "component",
                                "description": "integral component of membrane"
                            },
                            {
                                "category": "component",
                                "description": "mitochondrial membrane"
                            },
                            {
                                "category": "component",
                                "description": "nucleus"
                            },
                            {
                                "category": "component",
                                "description": "plasma membrane"
                            },
                            {
                                "category": "function",
                                "description": "ATP binding"
                            },
                            {
                                "category": "function",
                                "description": "ATPase activity, coupled to transmembrane movement of substances"
                            },
                            {
                                "category": "function",
                                "description": "heme transporter activity"
                            },
                            {
                                "category": "function",
                                "description": "protein homodimerization activity"
                            },
                            {
                                "category": "function",
                                "description": "transporter activity"
                            },
                            {
                                "category": "function",
                                "description": "xenobiotic-transporting ATPase activity"
                            },
                            {
                                "category": "process",
                                "description": "cellular iron ion homeostasis"
                            },
                            {
                                "category": "process",
                                "description": "drug transmembrane transport"
                            },
                            {
                                "category": "process",
                                "description": "heme transport"
                            },
                            {
                                "category": "process",
                                "description": "response to drug"
                            },
                            {
                                "category": "process",
                                "description": "small molecule metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "transmembrane transport"
                            },
                            {
                                "category": "process",
                                "description": "transport"
                            },
                            {
                                "category": "process",
                                "description": "urate metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "xenobiotic transport"
                            }
                        ]
                    }
                }
            },
            {
                "@position": "2",
                "id": "BE0001032",
                "name": "P-glycoprotein 1",
                "organism": "Humans",
                "actions": {
                    "action": "inhibitor"
                },
                "references": {
                    "articles": null,
                    "textbooks": null,
                    "links": {
                        "link": {
                            "ref-id": "L6652",
                            "title": "FDA Approved Drug Products: PIQRAY (alpelisib) tablets, for oral use",
                            "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212526s000lbl.pdf"
                        }
                    },
                    "attachments": null
                },
                "known-action": "unknown",
                "polypeptide": {
                    "@id": "P08183",
                    "@source": "Swiss-Prot",
                    "name": "Multidrug resistance protein 1",
                    "general-function": "Xenobiotic-transporting atpase activity",
                    "specific-function": "Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.",
                    "gene-name": "ABCB1",
                    "locus": "7q21.1",
                    "cellular-location": "Cell membrane",
                    "transmembrane-regions": "45-67\n117-137\n187-208\n216-236\n293-316\n331-352\n712-732\n757-777\n833-853\n855-874\n935-957\n974-995",
                    "signal-regions": null,
                    "theoretical-pi": "9.44",
                    "molecular-weight": "141477.255",
                    "chromosome-location": "7",
                    "organism": {
                        "@ncbi-taxonomy-id": "9606",
                        "#text": "Humans"
                    },
                    "external-identifiers": {
                        "external-identifier": [
                            {
                                "resource": "HUGO Gene Nomenclature Committee (HGNC)",
                                "identifier": "HGNC:40"
                            },
                            {
                                "resource": "GenAtlas",
                                "identifier": "ABCB1"
                            },
                            {
                                "resource": "GenBank Gene Database",
                                "identifier": "M14758"
                            },
                            {
                                "resource": "GenBank Protein Database",
                                "identifier": "307180"
                            },
                            {
                                "resource": "UniProtKB",
                                "identifier": "P08183"
                            },
                            {
                                "resource": "UniProt Accession",
                                "identifier": "MDR1_HUMAN"
                            }
                        ]
                    },
                    "synonyms": {
                        "synonym": [
                            "3.6.3.44",
                            "ATP-binding cassette sub-family B member 1",
                            "MDR1",
                            "P-glycoprotein 1",
                            "PGY1"
                        ]
                    },
                    "amino-acid-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0037114|Multidrug resistance protein 1\nMDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAII\nHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSG\nIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVS\nKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFT\nDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIG\nAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARG\nAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSG\nQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLF\nATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIA\nIARALVRNPKILLLDEATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAG\nFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRS\nSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAII\nNGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKA\nGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNI\nANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEA\nIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFG\nAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDS\nYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVV\nQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVV\nSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLD\nEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQL\nLAQKGIYFSMVSVQAGTKRQ"
                    },
                    "gene-sequence": {
                        "@format": "FASTA",
                        "#text": ">lcl|BSEQ0016291|Multidrug resistance protein 1 (ABCB1)\nATGGATCTTGAAGGGGACCGCAATGGAGGAGCAAAGAAGAAGAACTTTTTTAAACTGAAC\nAATAAAAGTGAAAAAGATAAGAAGGAAAAGAAACCAACTGTCAGTGTATTTTCAATGTTT\nCGCTATTCAAATTGGCTTGACAAGTTGTATATGGTGGTGGGAACTTTGGCTGCCATCATC\nCATGGGGCTGGACTTCCTCTCATGATGCTGGTGTTTGGAGAAATGACAGATATCTTTGCA\nAATGCAGGAAATTTAGAAGATCTGATGTCAAACATCACTAATAGAAGTGATATCAATGAT\nACAGGGTTCTTCATGAATCTGGAGGAAGACATGACCAGGTATGCCTATTATTACAGTGGA\nATTGGTGCTGGGGTGCTGGTTGCTGCTTACATTCAGGTTTCATTTTGGTGCCTGGCAGCT\nGGAAGACAAATACACAAAATTAGAAAACAGTTTTTTCATGCTATAATGCGACAGGAGATA\nGGCTGGTTTGATGTGCACGATGTTGGGGAGCTTAACACCCGACTTACAGATGATGTCTCC\nAAGATTAATGAAGGAATTGGTGACAAAATTGGAATGTTCTTTCAGTCAATGGCAACATTT\nTTCACTGGGTTTATAGTAGGATTTACACGTGGTTGGAAGCTAACCCTTGTGATTTTGGCC\nATCAGTCCTGTTCTTGGACTGTCAGCTGCTGTCTGGGCAAAGATACTATCTTCATTTACT\nGATAAAGAACTCTTAGCGTATGCAAAAGCTGGAGCAGTAGCTGAAGAGGTCTTGGCAGCA\nATTAGAACTGTGATTGCATTTGGAGGACAAAAGAAAGAACTTGAAAGGTACAACAAAAAT\nTTAGAAGAAGCTAAAAGAATTGGGATAAAGAAAGCTATTACAGCCAATATTTCTATAGGT\nGCTGCTTTCCTGCTGATCTATGCATCTTATGCTCTGGCCTTCTGGTATGGGACCACCTTG\nGTCCTCTCAGGGGAATATTCTATTGGACAAGTACTCACTGTATTCTTTTCTGTATTAATT\nGGGGCTTTTAGTGTTGGACAGGCATCTCCAAGCATTGAAGCATTTGCAAATGCAAGAGGA\nGCAGCTTATGAAATCTTCAAGATAATTGATAATAAGCCAAGTATTGACAGCTATTCGAAG\nAGTGGGCACAAACCAGATAATATTAAGGGAAATTTGGAATTCAGAAATGTTCACTTCAGT\nTACCCATCTCGAAAAGAAGTTAAGATCTTGAAGGGTCTGAACCTGAAGGTGCAGAGTGGG\nCAGACGGTGGCCCTGGTTGGAAACAGTGGCTGTGGGAAGAGCACAACAGTCCAGCTGATG\nCAGAGGCTCTATGACCCCACAGAGGGGATGGTCAGTGTTGATGGACAGGATATTAGGACC\nATAAATGTAAGGTTTCTACGGGAAATCATTGGTGTGGTGAGTCAGGAACCTGTATTGTTT\nGCCACCACGATAGCTGAAAACATTCGCTATGGCCGTGAAAATGTCACCATGGATGAGATT\nGAGAAAGCTGTCAAGGAAGCCAATGCCTATGACTTTATCATGAAACTGCCTCATAAATTT\nGACACCCTGGTTGGAGAGAGAGGGGCCCAGTTGAGTGGTGGGCAGAAGCAGAGGATCGCC\nATTGCACGTGCCCTGGTTCGCAACCCCAAGATCCTCCTGCTGGATGAGGCCACGTCAGCC\nTTGGACACAGAAAGCGAAGCAGTGGTTCAGGTGGCTCTGGATAAGGCCAGAAAAGGTCGG\nACCACCATTGTGATAGCTCATCGTTTGTCTACAGTTCGTAATGCTGACGTCATCGCTGGT\nTTCGATGATGGAGTCATTGTGGAGAAAGGAAATCATGATGAACTCATGAAAGAGAAAGGC\nATTTACTTCAAACTTGTCACAATGCAGACAGCAGGAAATGAAGTTGAATTAGAAAATGCA\nGCTGATGAATCCAAAAGTGAAATTGATGCCTTGGAAATGTCTTCAAATGATTCAAGATCC\nAGTCTAATAAGAAAAAGATCAACTCGTAGGAGTGTCCGTGGATCACAAGCCCAAGACAGA\nAAGCTTAGTACCAAAGAGGCTCTGGATGAAAGTATACCTCCAGTTTCCTTTTGGAGGATT\nATGAAGCTAAATTTAACTGAATGGCCTTATTTTGTTGTTGGTGTATTTTGTGCCATTATA\nAATGGAGGCCTGCAACCAGCATTTGCAATAATATTTTCAAAGATTATAGGGGTTTTTACA\nAGAATTGATGATCCTGAAACAAAACGACAGAATAGTAACTTGTTTTCACTATTGTTTCTA\nGCCCTTGGAATTATTTCTTTTATTACATTTTTCCTTCAGGGTTTCACATTTGGCAAAGCT\nGGAGAGATCCTCACCAAGCGGCTCCGATACATGGTTTTCCGATCCATGCTCAGACAGGAT\nGTGAGTTGGTTTGATGACCCTAAAAACACCACTGGAGCATTGACTACCAGGCTCGCCAAT\nGATGCTGCTCAAGTTAAAGGGGCTATAGGTTCCAGGCTTGCTGTAATTACCCAGAATATA\nGCAAATCTTGGGACAGGAATAATTATATCCTTCATCTATGGTTGGCAACTAACACTGTTA\nCTCTTAGCAATTGTACCCATCATTGCAATAGCAGGAGTTGTTGAAATGAAAATGTTGTCT\nGGACAAGCACTGAAAGATAAGAAAGAACTAGAAGGTTCTGGGAAGATCGCTACTGAAGCA\nATAGAAAACTTCCGAACCGTTGTTTCTTTGACTCAGGAGCAGAAGTTTGAACATATGTAT\nGCTCAGAGTTTGCAGGTACCATACAGAAACTCTTTGAGGAAAGCACACATCTTTGGAATT\nACATTTTCCTTCACCCAGGCAATGATGTATTTTTCCTATGCTGGATGTTTCCGGTTTGGA\nGCCTACTTGGTGGCACATAAACTCATGAGCTTTGAGGATGTTCTGTTAGTATTTTCAGCT\nGTTGTCTTTGGTGCCATGGCCGTGGGGCAAGTCAGTTCATTTGCTCCTGACTATGCCAAA\nGCCAAAATATCAGCAGCCCACATCATCATGATCATTGAAAAAACCCCTTTGATTGACAGC\nTACAGCACGGAAGGCCTAATGCCGAACACATTGGAAGGAAATGTCACATTTGGTGAAGTT\nGTATTCAACTATCCCACCCGACCGGACATCCCAGTGCTTCAGGGACTGAGCCTGGAGGTG\nAAGAAGGGCCAGACGCTGGCTCTGGTGGGCAGCAGTGGCTGTGGGAAGAGCACAGTGGTC\nCAGCTCCTGGAGCGGTTCTACGACCCCTTGGCAGGGAAAGTGCTGCTTGATGGCAAAGAA\nATAAAGCGACTGAATGTTCAGTGGCTCCGAGCACACCTGGGCATCGTGTCCCAGGAGCCC\nATCCTGTTTGACTGCAGCATTGCTGAGAACATTGCCTATGGAGACAACAGCCGGGTGGTG\nTCACAGGAAGAGATTGTGAGGGCAGCAAAGGAGGCCAACATACATGCCTTCATCGAGTCA\nCTGCCTAATAAATATAGCACTAAAGTAGGAGACAAAGGAACTCAGCTCTCTGGTGGCCAG\nAAACAACGCATTGCCATAGCTCGTGCCCTTGTTAGACAGCCTCATATTTTGCTTTTGGAT\nGAAGCCACGTCAGCTCTGGATACAGAAAGTGAAAAGGTTGTCCAAGAAGCCCTGGACAAA\nGCCAGAGAAGGCCGCACCTGCATTGTGATTGCTCACCGCCTGTCCACCATCCAGAATGCA\nGACTTAATAGTGGTGTTTCAGAATGGCAGAGTCAAGGAGCATGGCACGCATCAGCAGCTG\nCTGGCACAGAAAGGCATCTATTTTTCAATGGTCAGTGTCCAGGCTGGAACAAAGCGCCAG\nTGA"
                    },
                    "pfams": {
                        "pfam": [
                            {
                                "identifier": "PF00005",
                                "name": "ABC_tran"
                            },
                            {
                                "identifier": "PF00664",
                                "name": "ABC_membrane"
                            }
                        ]
                    },
                    "go-classifiers": {
                        "go-classifier": [
                            {
                                "category": "component",
                                "description": "cell surface"
                            },
                            {
                                "category": "component",
                                "description": "extracellular exosome"
                            },
                            {
                                "category": "component",
                                "description": "integral component of membrane"
                            },
                            {
                                "category": "component",
                                "description": "membrane"
                            },
                            {
                                "category": "component",
                                "description": "plasma membrane"
                            },
                            {
                                "category": "function",
                                "description": "ATP binding"
                            },
                            {
                                "category": "function",
                                "description": "ATPase activity, coupled to transmembrane movement of substances"
                            },
                            {
                                "category": "function",
                                "description": "transporter activity"
                            },
                            {
                                "category": "function",
                                "description": "xenobiotic-transporting ATPase activity"
                            },
                            {
                                "category": "process",
                                "description": "drug transmembrane transport"
                            },
                            {
                                "category": "process",
                                "description": "G2/M transition of mitotic cell cycle"
                            },
                            {
                                "category": "process",
                                "description": "response to drug"
                            },
                            {
                                "category": "process",
                                "description": "small molecule metabolic process"
                            },
                            {
                                "category": "process",
                                "description": "stem cell proliferation"
                            },
                            {
                                "category": "process",
                                "description": "transmembrane transport"
                            },
                            {
                                "category": "process",
                                "description": "transport"
                            }
                        ]
                    }
                }
            }
        ]
    }
}